ࡱ>  RTGHIJKLMNOPQa ljbjbtt fhhhhh   B 555866B }Wb7b7b7b7b7<<<pVrVrVrVrVrVrV,QYR[V <;@<<<V,@hhb7b7vV4,@,@,@<h8b78b7pV,@ rhhhh<pV,@,@T\VV7 iAn5?@4U\VV}WJUA\,@A\,\V,@ B B +5B B 5 Medicines Medicines play an important role in treatment for patients who have had a heart attack or who have heart failure. In most cases, people who have had a heart attack or who have heart failure require several types (categories) of medicines. Research has shown that medicines may help improve your heart function, reduce hospitalizations, and help you live a longer life. Some of the medicines used may also treat other conditions, such as high blood pressure, but we will focus on the dosing that is needed for heart failure. Your doctor may adjust your medicines and the doses from time to time so that you are taking the types and amounts of medicines that work best to treat your condition. Some of your medicines can cause side effects that may bother you or make you feel worse. If you have side effects, tell your doctor or nurse. Your doctor or nurse will work with you to minimize the side effects or change your medicine. In order to get the full benefit of these medicines, it is important that you take all of your medicines exactly as your doctor or nurse ordered even if you think your medicines are not making you feel better. Over time, being on the right medicines should make you feel better, all the more reason to keep taking the medicines as prescribed, at the same dose and at the same time every day. You may have other medical conditions such as high blood pressure, diabetes, asthma, or arthritis that need treatment with medicines. You may also be taking over-the-counter drugs (medicine you can buy without a prescription) or herbal therapies that do not require a prescription from a doctor. Sometimes these drugs or therapies may interact with your heart failure medicines and make your heart failure worse or cause risky side effects. Tell your doctor or nurse about all of your medical conditions and all medicines or over-the-counter drugs you are taking. Your doctor or nurse will then be able to develop the best treatment plan for you. Not everyone responds to treatments in the same way, and your results may be different from other people. Refer to the manufacturers prescribing information or instructions for use before taking any medications. Medicine Names It is helpful to understand a little about how medicines are named, so you can better understand the types of medicines your doctor has prescribed and feel more comfortable talking with your doctor or nurse about your treatment plan. Most medicines have two names: Brand name the name a company uses to market the medicine. This is sometimes followed by a registered symbol ((). Generic name the name that describes the active chemical in a medicine Here are some examples of these two types of names: Type of medicine: pain reliever Brand name: Tylenol( Generic name: acetaminophen Type of medicine: angiotensin converting enzyme (ACE) inhibitor Brand name: Vasotec( Generic name: enalapril Your doctor, nurse, pharmacist, or other healthcare provider may use either the generic or the brand name, but both names refer to the same medicine. In some cases, a generic medicine is sold by more than one company, and each company assigns its own brand name. If the pharmacy changes brand names, you can do two things to make sure you are getting the right medicine: Check the generic name and dosage to make sure it is what you are supposed to take Ask your pharmacist to explain any differences The major types of medicines used to treat heart failure or to treat a weakened heart muscle after a heart attack are described below by type (or category). You will see important information for each type of medicine. You may want to write down this information for all of the medicines your doctor has prescribed for you. Angiotensin Converting Enzyme (ACE) Inhibitor This category of medicine may be the first treatment your doctor prescribes ACE inhibitors help reduce the hearts workload by blocking certain harmful hormones your body produces that cause the heart to work harder ACE inhibitors are also used to treat patients with high blood pressure or after a heart attack. They are sometimes used to protect the kidneys in patients with diabetes. Over time (from weeks to months), ACE inhibitors may eliminate your symptoms and prevent worsening heart failure They have been shown to prolong life in people with heart failure When the heart muscle is weaker than normal, the body produces chemicals to help the heart pump more strongly. Over time, these chemicals can damage the heart muscle and cause it to get weaker. ACE inhibitors protect the heart muscle from harmful chemicals and may increase heart muscle strength over time. ACE inhibitors are also used to treat patients with high blood pressure, patients who have had a heart attack, and patients with diabetes How to Take ACE Inhibitors The ACE inhibitor dose will vary depending on which ACE inhibitor is chosen for you and what condition is being treated You should always take this medicine exactly as it is prescribed by your doctor Your doctor or healthcare team may increase the dose of your ACE inhibitor even if you are feeling fine or have only mild symptoms. This can be confusing to some patients. Research has shown that higher doses may protect your heart better than lower doses. Your doctor and healthcare team will choose the right dose for you. You should not take this medicine if you are pregnant. This medicine is known to cause birth defects. If you plan to become pregnant, let your doctor or nurse know right away. If you become pregnant or are concerned you may be pregnant, let your doctor or nurse know immediately. Possible Side Effects Common side effects include dizziness, an unusual taste in your mouth or loss of taste, low blood pressure, and dry cough You should report any side effects to your doctor immediately Severe dizziness, fainting, rash, and swelling of the face are rare side effects If you have ever had an allergic reaction to an ACE inhibitor, be sure to tell your doctor Blood will be drawn periodically to check on your kidney functioning and potassium levels Safety Measures ACE inhibitors may cause you to feel dizzy when you stand up after sitting or when you get up after lying down. Remember to always stand up slowly. This will make you feel less dizzy and will help you avoid falling. If this dizziness is mild, your doctor may not change the dose or stop this medication. Do not use salt substitutes without approval from your doctor or nurse Avoid using medicines such as ibuprofen (Advil) or other NSAIDs (non-steroidal anti-inflammatory drugs, such as Anaprox or Naprosyn) while you are taking an ACE inhibitor Before you take an over-the-counter drug, you should always ask your doctor or pharmacist if it is OK to take it with your ACE inhibitor If you are pregnant or plan to become pregnant, you should not take an ACE inhibitor. Be sure to talk to your doctor or nurse. Talk to your doctor, nurse, or pharmacist for more information about this medication Angiotensin Receptor Blocker (ARB) ARBs block the same chemicals that ACE inhibitors do, but they work in a different way to reduce the hearts workload ARBs can also be used to treat high blood pressure An ARB is often prescribed when a heart failure patient cannot tolerate an ACE inhibitor due to side effects that cannot be minimized. In some cases, your doctor may want you to take both an ACE inhibitor and an ARB. Side effects include dizziness and low blood pressure How to Take ARBs The ARB dose will vary depending on which ARB is chosen for you and what condition is being treated You should always take this medicine exactly as it is prescribed by your doctor You should take your medicine at the same time each day. This will help you to remember to take it. If you are taking the ARB more than once each day, you should space out the doses as evenly as possible. You should not take this medicine if you are pregnant. This medicine is known to cause birth defects. If you plan to become pregnant, let your doctor or nurse know right away. If you become pregnant or are concerned you may be pregnant, let your doctor or nurse know immediately. Possible Side Effects Dizziness and lightheadedness are some of the common side effects of ARBs If you have ever had an allergic reaction to an ACE inhibitor, be sure to tell your doctor. It is unlikely that you would also be allergic to an ARB, but your doctor should be aware of your medication history. Safety Measures ARBs may cause you to feel dizzy when you stand up after sitting or when you get up after lying down. Remember to always stand up slowly. This will make you feel less dizzy and will help you avoid falling. If this dizziness is mild, your doctor may not change the dose or stop this medication. Do not use salt substitutes without approval from your doctor or nurse Before you take an over-the-counter drug, you should always ask your doctor or pharmacist if it is OK to take it with your ARB If you are pregnant or plan to become pregnant, you should not take an ARB. Be sure to talk to your doctor or nurse. Please talk to your doctor, nurse, or pharmacist for more information about this medication Beta Blocker A beta blocker is used to treat heart failure and for people who have had a heart attack to prevent them from having another one When the heart muscle is weaker than normal, the body produces chemicals to help the heart pump more strongly. Over time, these chemicals can damage the heart muscle and cause it to get weaker. A beta blocker protects the heart muscle from harmful chemicals and may increase heart muscle strength over time. Beta blockers can also be used to treat other conditions, such as high blood pressure and angina (chest pain), or be given to patients who have abnormal heart rhythms. How to Take a Beta Blocker The beta blocker dose will vary depending on which beta blocker is chosen for you and what condition is being treated You will be started on a low dose of medicine at first. The dose will be increased slowly over time. You should take your medicine at the same time each day. This will help you to remember to take it. Your doctor or healthcare team may increase the dose of your beta blocker even if you are feeling fine or have only mild symptoms. This can be confusing to some patients. Research has shown that higher doses may protect your heart better than lower doses. Your doctor and healthcare team will choose the right dose for you. Do not stop this medication without discussing it with your doctor. Doing so can be dangerous. Do not let your medication run out Possible Side Effects Common side effects include initial fatigue (for 1-4 weeks) and mild dizziness Severe dizziness, fainting, slow heartbeat, and wheezing are also possible side effects, but they are less common Some people will have a lack of energy and feel tired for the first several weeks after starting a beta blocker. However, after about 1-2 months, patients generally start to feel much better and have more energy because of the beta blocker. Erectile dysfunction can occur when taking a beta blocker. If this happens to you, discuss it with your doctor or nurse. There are medicines that can help with this problem that are safe for people with mild to moderate heart failure. Safety Measures Beta blockers may cause you to feel dizzy when you stand up after sitting or when you get up after lying down, so remember to always stand up slowly. This will make you feel less dizzy and will help you avoid falling. You should never suddenly stop taking your daily dose of beta blocker. If your doctor wants you to stop taking a beta blocker, the dose will be decreased slowly (over a few days or weeks). Do not stop this medication without discussing it with your doctor. Doing so can be dangerous. Do not let your medication run out Please talk to your doctor, nurse, or pharmacist for more information about this medication Diuretic Sometimes called water pills, diuretics help your body get rid of excess fluid and, in doing so, may improve problems of swelling and fatigue You should weigh yourself first thing every morning, and keep a record, to watch for fluid gain or loss Find out your baseline weight, also called your dry weight. If your weight increases by 3 pounds overnight or 5 pounds over 2 days, call your doctor or nurse. Your diuretic dose may be changed based on your changes in weight or specific parameters set by your doctor or nurse Diuretics can also be used to treat high blood pressure How to Take Diuretics The diuretic dose will vary depending on which diuretic is chosen for you and your symptoms Take your diuretic at the same time each day, usually first thing in the morning. Plan on staying close to home for the first several hours after taking it, as it will cause you to urinate frequently. Many times, diuretics are taken twice a day in order to better control symptoms. Take the second dose in the middle of the afternoon to avoid being up all night going to the bathroom. Some patients are prescribed two diuretics. If you are prescribed metolazone or hydrochlorothiazide in combination with another diuretic (usually furosemide, bumetanide, or torsemide), the metolazone or hydrochlorothiazide should be taken 30 to 60 minutes before the other diuretic to help the other diuretic work better. Do not drink excessive fluids when you have heart failure and take diuretics. Take sips of water only when you are thirsty or with your pills. Drink small amounts of fluids with meals. Diuretics remove excess fluid and, by drinking more, you can make them ineffective in improving your symptoms. Possible Side Effects Leg cramps, dry mouth, and frequent urination are the most common side effects of diuretics Diuretics may cause increased thirst Safety Measures Diuretics may cause you to feel dizzy when you stand up after sitting or when you get up after lying down. Remember to always stand up slowly. This will make you feel less dizzy and will help you avoid falling. Most diuretics can cause you to lose potassium. You will likely be prescribed a potassium supplement. Before taking an over-the-counter medicine, always ask your doctor, nurse, or pharmacist if it is OK to take with your diuretic Please talk to your doctor, nurse, or pharmacist for more information about this medication Aldosterone Antagonist This type of medicine blocks the effects of the hormone aldosterone Aldosterone can cause the heart muscle to get bigger and stiffer. This may decrease how well your heart pumps. Aldosterone also causes your body to retain sodium (salt) and water, and that may make you bloated and congested. Aldosterone antagonists help improve heart function and also relieve congestion This category of medicine is also used to treat high blood pressure, but at a different dose Side effects include breast enlargement or tenderness, especially in men, and increased potassium levels How to Take Aldosterone Antagonists You should always take this medicine exactly as it is prescribed by your doctor The dose may vary depending on what other medications you are taking You should take your medicine at the same time each day. This will help you to remember to take it. Possible Side Effects Common side effects include dizziness, breast tenderness, development of breast tissue in men (gynecomastia), and high potassium level Your doctor will check your blood on a regular basis when you begin this medicine to monitor the level of potassium in your blood. It is important to get lab work as prescribed by your doctor or nurse. Safety Measures These medicines may cause you to feel dizzy when you stand up after sitting or when you get up after lying down. Remember to always stand up slowly. This will make you feel less dizzy and will help you avoid falling. Be sure to tell your doctor about each of your medications, and whether you are taking a potassium supplement or use a salt substitute Do not use salt substitutes. You may be asked to stop using them. Before you take an over-the-counter medicine, you should always ask your doctor or pharmacist if it is OK to take it with your aldosterone antagonist Please talk to your doctor, nurse, or pharmacist for more information about this medication Digoxin This type of medicine can help your heart pump more forcefully and efficiently In patients with abnormal heart rhythms, it can also be used to help the heart beat more slowly and more regularly Digoxin helps patients with heart failure breathe more easily, decreases their fatigue, and increases their ability to exercise Side effects include nausea or vomiting, blurry vision, and abnormal heart rhythms How to Take Digoxin You should always take this medicine exactly as it is prescribed by your doctor You should take your medicine once a day, at the same time each day or as prescribed by your doctor or nurse Possible Side Effects Nausea is a possible side effect when taking digoxin Tell your doctor if you notice a change in your vision, especially in your ability to see colors such as blue, yellow, or green, or if your vision seems more blurry than usual If you have lost your normal appetite or lost a surprising amount of weight, you should contact your doctor Safety Measures There are many drugs, including over-the-counter medicines, that affect digoxin Some medicines may cause too much digoxin to stay in your system, and others may reduce the amount that gets into your system Before you take an over-the-counter medicine, you should always ask your doctor or pharmacist if it is OK to take it with digoxin Please talk to your doctor, nurse, or pharmacist for more information about this medication Hydralazine Hydralazine is used to treat heart failure and can also be used to treat high blood pressure It causes the arteries in your body to dilate (get bigger). This lowers your blood pressure and decreases the hearts workload. How to Take Hydralazine You should always take this medicine exactly as it is prescribed by your doctor You should take your medicine at the same time each day. It is important to wait the same amount of time between each dose of your hydralazine throughout the day. This will help keep the levels of hydralazine constant in your blood. Possible Side Effects Common side effects include headache, abdominal pain, dizziness, and lightheadedness Contact your doctor or nurse if you notice any new or unusual symptoms of arthritis, joint pain or swelling, or rashes Safety Measures Hydralazine may cause you to feel dizzy when you stand up after sitting or when you get up after lying down. Remember to always stand up slowly. This will make you feel less dizzy and will help you avoid falling. Before you take an over-the-counter medicine, you should always ask your doctor or pharmacist if it is OK to take it with hydralazine Please talk to your doctor, nurse, or pharmacist for more information about this medication Nitrate Nitrates can be used to treat angina (chest pain) or high blood pressure, and are also used to help relieve congestion in patients with heart failure Nitrates allow the blood vessels to get bigger to allow more blood to carry oxygen to the heart. They also take pressure off of the top part of the heart, so the heart does not have to work as hard. How to Take Nitrates You should always take this medicine exactly as it is prescribed by your doctor You should take your medicine once a day, at the same time each day. This will help you remember to take it. If you take this medicine more than once a day, it is important to take it at specific times so that you have a 10 to 14 hour period when the medicine is out of your system. This will help the nitrate work better and will prevent your body from becoming tolerant to it. If you have been prescribed isosorbide mononitrate, you should take your dose at 7 am If you have been prescribed isosorbide dinitrate, you should take your last dose by 5 pm If you have been prescribed a nitroglycerin patch, the patch should be off for 10 to 14 hours of every day (that means you wear it for 10 to 14 hours over a 24-hour period) Your doctor may have other individual instructions regarding the way you take your nitrates. You should follow your doctors instructions. Possible Side Effects Common side effects include dizziness, abdominal pain, and headache Safety Measures You should not take any form of nitrates with the medication sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra), or other erectile dysfunction medications similar to these. This combination can cause a fatally low blood pressure. Nitrates may cause you to feel dizzy when you stand up after sitting or when you get up after lying down. Remember to always stand up slowly. This will make you feel less dizzy and will help you avoid falling. Before you take an over-the-counter medicine, you should always ask your doctor or pharmacist if it is OK to take it with your nitrate Please talk to your doctor, nurse, or pharmacist for more information about this medication Note: There is a fixed-dose combination of hydralazine and nitrate called BiDil Statin Statins are used to treat high cholesterol Your doctor has prescribed this medicine for you because some, or all of your cholesterol levels are higher than the range that your doctor has set as your goal How to Take Statins You should always take this medicine exactly as it is prescribed by your doctor You should take your medicine at the same time each day, day or night, as recommended by your doctor or nurse Possible Side Effects The most common side effect of statins is an upset stomach. You can prevent this by taking your statin with food. This medicine can also affect your liver. Your doctor will check your liver enzymes with a blood test before you start taking your statin and every 6 months while you are on the medicine. In some cases, statins can cause muscle aches and weakness, like the flu. This is a rare side effect, but if you feel flu-like symptoms you should call your doctor or nurse. Safety Measures Some statins can interact with other medications Before you take an over-the-counter medicine, you should always ask your doctor or pharmacist if it is OK to take it with your statin Please talk to your doctor, nurse, or pharmacist for more information about this medication Warfarin Warfarin is an anticoagulant, which means that it prevents blood clots from forming or stops a blood clot from getting bigger Warfarin is used to thin the blood in patients with abnormal heart rhythms, patients who have a history of stroke or clots in the lungs or legs, or patients who have had certain types of heart valves replaced How to Take Warfarin You should always take this medicine exactly as it is prescribed by your doctor You should take your medicine once a day, at the same time each day. This will help you to remember to take it. The dose of warfarin will be different for every patient. It depends on your individual response to the medicine, and also on your bodys absorption and metabolism. Your doctor will determine the correct dose for you by checking a blood test called the INR (international normalized ratio). The INR test measures how hard it is for your blood to clot. You should know your INR. Discuss this with your doctor. Possible Side Effects Most of the serious side effects of warfarin occur when the medicine level is too much or too little for a patient (when the INR is too low or too high) Bleeding is the most common side effect. Serious bleeding rarely occurs when the INR is in the correct range. Some people find that they bruise more easily than usual, or have nosebleeds or bleeding gums. It is not unusual to make an adjustment in your warfarin dosing after every INR lab test. Other side effects of warfarin include loss of appetite, nausea or diarrhea, irritated or itchy skin, and hair loss Safety Measures Many medicines can change the way warfarin works. Some medicines increase warfarins effects and can cause bleeding. Other medicines decrease the actions of warfarin and may prevent your blood from thinning at the right level. Vitamin K interferes with warfarin and can make it ineffective. Vitamin K is found in certain multivitamins and many foods, especially dark green leafy vegetables, including foods in the list below: Asparagus Lettuce Avocado Liver Broccoli Mustard greens Brussels sprouts Parsley Cabbage Peas (including black-eyed peas, split peas, and chickpeas) Cauliflower Soybeans and soybean oil Collard greens Spinach Kale Turnip greens The best thing to do is keep your intake of foods with vitamin K constant while you are on warfarin. This means that you shouldnt eat a lot more or a lot less of foods with vitamin K than you normally do. You should not drink alcohol when taking warfarin You should not take this medicine if you are pregnant. This medicine is known to cause birth defects. If you plan to become pregnant, let your doctor know right away. If you become pregnant or are concerned you may be pregnant, please let your doctor or nurse know immediately. Many medications interact with warfarin. Before you take any new medication, including over-the-counter medicines, you should always ask your doctor, nurse, or pharmacist if it is OK to take it with warfarin. Taking warfarin with amiodarone, coumadin, and antibiotics are common mistakes. Please talk to your doctor, nurse, or pharmacist for more information about this medication Developed by the SCA Prevention Medical Advisory Team. This material is intended to be educational. It is not intended to replace the information provided to you by your healthcare providers and may not be directly applicable for your individual clinical circumstance. Please refer to the manufacturers prescribing information and/or instructions for use for the indications, contraindications, warnings, and precautions associated with the medications and devices referenced in these materials. Sponsored by Medtronic, Inc. May 2007 UC200705509 EN       XY&)LM$%noN Q   G K L Q w z   0 ܶhCJOJQJ^JaJ hhCJOJQJ^JaJ.jhCJOJQJU^JaJmHnHu!hi;hB*OJQJ^Jphg)hi;hB*CJ$OJQJ^JaJ$phghB*OJQJ^Jphg*jhjEhB*OJQJU^Jphg-MH I J K L M N O P Q R   IJdgd$a$gd`gdllll0 3 S V HABEQnǵǢr`rKr`r=r`r`rhCJOJQJ^JaJ) jhrhCJH*OJQJ^JaJ#hrh5CJOJQJ^JaJ hrhCJOJQJ^JaJ!hi;hB*OJQJ^JphghB*OJQJ^Jphg%hi;hB*CJOJQJ^Jph#hB*CJOJQJ^JaJph)hhB*CJOJQJ^JaJph hhCJOJQJ^JaJ#hh5CJOJQJ^JaJEUjdgd & F hLd^`Lgddgdgd'_hijv-L\{$C/ bٹٹٹٹٹ٬ٹٹٹٹ|mٹٹh5CJOJQJ^JaJ h>fhCJOJQJ^JaJ!hi;hB*OJQJ^JphghB*OJQJ^Jphghi;hOJQJ^JhCJOJQJ^JaJ#hrh5CJOJQJ^JaJ hrhCJOJQJ^JaJ) jhrhCJH*OJQJ^JaJ*M}~D{/b  & F hEd^`Egd & F hLd^`Lgdgddgd & F hdgd ./EO  hdgd & F hdgd & F hLd^`Lgddgd hd^hgd & F DLd^`Lgd & F Ld^`Lgd  @./89=DEb/N E     9 8!A!C!x!!!!ᾯᾯᖒ hZhCJOJQJ^JaJh hrh#hrhCJH*OJQJ^JaJh5CJOJQJ^JaJ#hrh5CJOJQJ^JaJ h>fhCJOJQJ^JaJ hrhCJOJQJ^JaJhCJOJQJ^JaJ/E; C!!!!!5"h"A#w#x## DLd^`Lgd  dgd & F hLd^`Lgdgddgd & F hLd^`Lgd & F hLd^`Lgd!!!!"4"H"g"""W#v#x########$=$ % %"&$&-&.&2&9&:&M&d&&W'^'f'g'((3)S)))пn hihCJOJQJ^JaJ h>fhCJOJQJ^JaJh5CJOJQJ^JaJ#hrh5CJOJQJ^JaJhCJOJQJ^JaJ hrhCJOJQJ^JaJ!hi;hB*OJQJ^JphghB*OJQJ^Jphg h QDhCJOJQJ^JaJ+##>$ %#&$&:&&V'W'g'((S))$* & F hLd^`Lgd & F hLd^`Lgd DLd^`Lgd & F hLd^`Lgd & F hDLd^`Lgd)))*)*6*7*>***a++++++,-,^,a,s,,,,,,,,,,,,,-&-k-----..4../6/}/////±ПП h>fhCJOJQJ^JaJh5CJOJQJ^JaJ#hrh5CJOJQJ^JaJ!hi;hB*OJQJ^JphghB*OJQJ^Jphg hrhCJOJQJ^JaJhCJOJQJ^JaJ hihCJOJQJ^JaJ2$*%*&*'*(*)*7**+,,,'--- Ld^`Lgd  dgd & F hDLd^`Lgd L^`Lgd  Ddgd DLd^`Lgd-6/////001n2o22Z34w4444 DL^`Lgd & F hDdgd Ld^`Lgd & F hDLd^`Lgd & F hLd^`Lgd///////// 00000q0001Y1y111/242o2~222x333344444455555567)7H7I7J7Q7R7V7_7`79пппппппппппппЮпРЮЮЮЮޮ!hi;hB*OJQJ^JphghB*OJQJ^Jphg h>fhCJOJQJ^JaJ hrhCJOJQJ^JaJhCJOJQJ^JaJ#hrh5CJOJQJ^JaJh5CJOJQJ^JaJ7444455567I7J7`778=9:; Ld^`Lgd & F hDLd^`Lgd L^`Lgd  Dgd DL^`Lgd99::::;;;;;;;;;;<A<B<I<Q<R<%=)=:=h=q======= >G>o>>>>>??9@ۼ͊ͼͼͼͼͼͼ|kͼͼ!hi;hB*OJQJ^JphghB*OJQJ^Jphg h{VhCJOJQJ^JaJh5CJOJQJ^JaJ#hrh5CJOJQJ^JaJ hrhCJOJQJ^JaJhCJOJQJ^JaJ h>䴳ϴ&>;5䴳ϴ*;;;<A<B<R<%== >g>h>i>j>k>l>  Dgd DL^`Lgd & F hDLd^`Lgd & F Ld^`Lgd Ld^`Lgd Ld^`Lgdl>m>n>o>>>??Y@@@@8A}AAA  Ddgd & F hLd^`Lgd Ld^`Lgd  dgd & F hDLd^`Lgd Ld^`Lgd  Dgd9@X@@@@@@@@@@@@@A7A]A|AAAAAAAAAA B BBBBCC@CACMC\C]C6DDDDDD]E^EvEEEEEhB*OJQJ^Jphg h{VhCJOJQJ^JaJ hjhCJOJQJ^JaJh5CJOJQJ^JaJ#hrh5CJOJQJ^JaJ hrhCJOJQJ^JaJhCJOJQJ^JaJ3AABLCMC]C6DDDEEEEEKFF>GGG  Ddgd Ld^`Lgd DLd^`Lgd Ld^`Lgd & F hDLd^`LgdEE+FJFFFG=GqGGGGGGGGGGH^]^r^s^^^_0_2_F_ﶨ h]VhCJOJQJ^JaJ!hi;hB*OJQJ^JphghB*OJQJ^JphghOJQJaJ#h %h5CJOJQJ^JaJh5CJOJQJ^JaJhCJOJQJ^JaJ h %hCJOJQJ^JaJ-EYYYYYYYOZZZZF[\\\\\y]]  dgd & F hEd^`Egd Ed^`Egd  Ddgd & F hDEd^`Egd]]]]^^1_2_H__``qWW & F hDLd^`Lgd & F hLd^`Lgd Ld^`Lgd  dgd & F Ld^`Lgd Ld^`Lgd DLd^`Lgd DEd^`Egd F_H_x__haaaaa3bRb!c{cccccddeeeeeeeeeeeeeeeef ffffff$f`faflfrfffffffffgg~hhhhhhhhhܿܿܮή h$KhCJOJQJ^JaJh5CJOJQJ^JaJhCJOJQJ^JaJ h]VhCJOJQJ^JaJ#h]Vh5CJOJQJ^JaJA`iaaaaTb|ccddeeeef`ffffggh & F Dd^`gd Ld^`Lgd & F hDLd^`Lgdhh-i.iiiiii6jUjVjWjZj_j`jajjjwjjjpkkkkkkkkkkklܽνwododoSoSoSoSoSoS!HhHhhCJaJh5ahCJaJhCJaJhi;hOJQJ^Jhi;hCJOJQJ^JhCJOJQJ^J hrhCJOJQJ^JaJh9hOJQJaJ h]VhCJOJQJ^JaJhCJOJQJ^JaJ h$KhCJOJQJ^JaJ#h$Kh5CJOJQJ^JaJ hiVjWjXjYjZj[j\j]j^j_j`jajjUlVlgd$a$gd$ !*J]Ja$gdgd  Ddgd Dgd DLd^`Lgd & F hDLd^`Lgdll;l>lTlWlsltlwl|l}llllllllllllllllllllllբ{uud!jhhOJQJU^J hCJjphjEhCJUhB*CJOJQJphhjhU h<-hCJOJQJ^JaJhh0JCJaJh0JCJaJhhCJaJhCJaJ!HhHhhCJaJ!HhlhhCJaJVltl}llllllllllllllllllllllS]S$a$gd`gd$a$gd$a$gd $ a$gdlll$a$gd:&P1h/R :p/ =!8"#h$%#FiY%ˆ%j:BJFIF}}6ExifMM*bj(1r2iAdobe Photoshop CS Macintosh2005:07:15 14:04:17Š&(.HH#Photoshop 3.08BIM8BIM%F &Vڰw8BIM com.apple.print.PageFormat.PMHorizontalRes com.apple.print.ticket.creator com.apple.printingmanager com.apple.print.ticket.itemArray com.apple.print.PageFormat.PMHorizontalRes 72 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2005-05-24T15:07:07Z com.apple.print.ticket.stateFlag 0 com.apple.print.PageFormat.PMOrientation com.apple.print.ticket.creator com.apple.printingmanager com.apple.print.ticket.itemArray com.apple.print.PageFormat.PMOrientation 1 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2005-05-24T15:07:07Z com.apple.print.ticket.stateFlag 0 com.apple.print.PageFormat.PMScaling com.apple.print.ticket.creator com.apple.printingmanager com.apple.print.ticket.itemArray com.apple.print.PageFormat.PMScaling 1 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2005-05-24T15:07:07Z com.apple.print.ticket.stateFlag 0 com.apple.print.PageFormat.PMVerticalRes com.apple.print.ticket.creator com.apple.printingmanager com.apple.print.ticket.itemArray com.apple.print.PageFormat.PMVerticalRes 72 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2005-05-24T15:07:07Z com.apple.print.ticket.stateFlag 0 com.apple.print.PageFormat.PMVerticalScaling com.apple.print.ticket.creator com.apple.printingmanager com.apple.print.ticket.itemArray com.apple.print.PageFormat.PMVerticalScaling 1 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2005-05-24T15:07:07Z com.apple.print.ticket.stateFlag 0 com.apple.print.subTicket.paper_info_ticket com.apple.print.PageFormat.PMAdjustedPageRect com.apple.print.ticket.creator com.apple.printingmanager com.apple.print.ticket.itemArray com.apple.print.PageFormat.PMAdjustedPageRect 0.0 0.0 734 576 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2005-07-15T17:23:47Z com.apple.print.ticket.stateFlag 0 com.apple.print.PageFormat.PMAdjustedPaperRect com.apple.print.ticket.creator com.apple.printingmanager com.apple.print.ticket.itemArray com.apple.print.PageFormat.PMAdjustedPaperRect -18 -18 774 594 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2005-07-15T17:23:47Z com.apple.print.ticket.stateFlag 0 com.apple.print.PaperInfo.PMPaperName com.apple.print.ticket.creator com.apple.print.pm.PostScript com.apple.print.ticket.itemArray com.apple.print.PaperInfo.PMPaperName na-letter com.apple.print.ticket.client com.apple.print.pm.PostScript com.apple.print.ticket.modDate 2003-07-01T17:49:36Z com.apple.print.ticket.stateFlag 1 com.apple.print.PaperInfo.PMUnadjustedPageRect com.apple.print.ticket.creator com.apple.print.pm.PostScript com.apple.print.ticket.itemArray com.apple.print.PaperInfo.PMUnadjustedPageRect 0.0 0.0 734 576 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2005-05-24T15:07:07Z com.apple.print.ticket.stateFlag 0 com.apple.print.PaperInfo.PMUnadjustedPaperRect com.apple.print.ticket.creator com.apple.print.pm.PostScript com.apple.print.ticket.itemArray com.apple.print.PaperInfo.PMUnadjustedPaperRect -18 -18 774 594 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2005-05-24T15:07:07Z com.apple.print.ticket.stateFlag 0 com.apple.print.PaperInfo.ppd.PMPaperName com.apple.print.ticket.creator com.apple.print.pm.PostScript com.apple.print.ticket.itemArray com.apple.print.PaperInfo.ppd.PMPaperName US Letter com.apple.print.ticket.client com.apple.print.pm.PostScript com.apple.print.ticket.modDate 2003-07-01T17:49:36Z com.apple.print.ticket.stateFlag 1 com.apple.print.ticket.APIVersion 00.20 com.apple.print.ticket.privateLock com.apple.print.ticket.type com.apple.print.PaperInfoTicket com.apple.print.ticket.APIVersion 00.20 com.apple.print.ticket.privateLock com.apple.print.ticket.type com.apple.print.PageFormatTicket 8BIMxHH@Rg(HH(dh 8BIM}}8BIM&?8BIM 8BIM8BIM 8BIM 8BIM' 8BIMH/fflff/ff2Z5-8BIMp8BIM@@8BIM8BIM901nullboundsObjcRct1Top longLeftlongBtomlongRghtlongslicesVlLsObjcslicesliceIDlonggroupIDlongoriginenum ESliceOrigin autoGeneratedTypeenum ESliceTypeImg boundsObjcRct1Top longLeftlongBtomlongRghtlongurlTEXTnullTEXTMsgeTEXTaltTagTEXTcellTextIsHTMLboolcellTextTEXT horzAlignenumESliceHorzAligndefault vertAlignenumESliceVertAligndefault bgColorTypeenumESliceBGColorTypeNone topOutsetlong leftOutsetlong bottomOutsetlong rightOutsetlong8BIM( ?8BIM8BIM8BIM!SAdobe PhotoshopAdobe Photoshop CS8BIMAhttp://ns.adobe.com/xap/1.0/ 4294967295 453 748 1 150/1 150/1 3 2005-07-15T14:04:17-04:00 2005-07-15T14:04:17-04:00 2005-07-15T14:04:17-04:00 Adobe Photoshop CS Macintosh uuid:80214e4a-f6ca-11d9-972b-fdeb51616705 adobe:docid:photoshop:80214e49-f6ca-11d9-972b-fdeb51616705 adobe:docid:photoshop:80214e4d-f6ca-11d9-972b-fdeb51616705 image/jpeg Adobed@9    ! 1AQ"aq2#B3$RbrSs%g)c4&ᢲCuV“ÔU6v'7(9  !1AQaq"2BRb#r34CS$ecD5'(s%ғT ?` 0` 0` 0` 0` 0` 0` 0П` 0`+/ݵblLwL(6JYV*bUÆicHc*[RΤI'ǾZdzE5Sȯ TA7M?V*~#_C}pzG/@p{~ϳ[`iM뇑-UjmؖIB$5z51|r NfKXT|w|~^F5TPjk]$'s{=ؔ4 ݊rc(G& =LTbx1L)4֥kA0` 0` 0` 0џ` 0nN{{opWrԪȌm'%H^yS'0:ҧc>Jȩmq QVM@[PKZkdO;~%.AMHjbD@DU=p]mnwgzCW7-9 k6)Yf=lZ!<JUZH"&dlD9{SҌWX=mN?Ֆ,Wו/Bt &V>=ٳ,/Q{o)vQ6$+B1$"z?2O0a?=(RTU#ʇ9#=OM/ f> aBA䴅q(tWRGja^u{#J:oIL];Wv8UzkCٜVW.NK#,AUKݼA*eIDzeO:Sxno>ķJ5/$UKjmp-t#JSc&P/*M%CGdӯ#_U%fFaL谔,2|\frHT @)G9 ubNȇn[Yy*ĩVu;_?o -hI0WW!xhHߘ,brT0(@*![~ym++W*z_ųtZ"͌ǣҿE.o}Z;FZfu$@"!3 I{tJˏ2'H2~^҉3^0jFd<)Rm\&v^2;7Se׳-_x[/}p[4: Sh=/h~gcI{M7o$Ihv q`IẍoT)~2|*mcDM#xe,:::8Jpn\{3-[qbVlU+;LQ(yh0z,'N{7nɒ}ISҨ_֛OrKѺ rRyI# T88rhȼM0)"DbUj:~bCj?/,yǛs-E*+ J-*&\  M]=nj{Pc5ؚ~j-R892p[el Wuo6T% dHD`/P7Pi{8[C"Q,Sd{sQ]m@B1I'5ݚe u4gbs~$?o_0`fگ>,^^S2v(dOm 3Y%p囔n틅h#퓴 $YtJtR9ѕ؟aQ$ i ES LU7dNIJi- %B6Mo)5۹@*"e01EMQ _*Y~(p6Iy@,ܥoZJ&nSwLb ݘ}~O|^u^BPqw4M2FiK ԰Gh^ ;b.4ǴvRKRVDpZ` 0` 0` 0ӟƟ?xa=X/)" lۺdXYF-6EIuL24h *'&QhB?+y|{k(ƣ)q['KYJeW"bk-]1W!`DS"6bFNf,kվk?h٤,S̔̂|uVT9|G0]I-o[BHִNƌ dnpxΞc(u N-o* qs%.ע3o?;7 ~5+5ڪJluۦșuqaCd3X uy:[n>joxve ܗK3O5zVk"LZk -Ғj#K]MlR@ȸMP{٤75YdIGz"4qo<gwHh;ƺC]o5WTR={&H|yc^ND9:Rz VU@HLR7v,ZƇ˳mF/M~%Z0v1zCӯAzeႧVrnȬ#t\"sf^-/hr*'f\Jo53D>,+<ξ&8ySq觴AQ&eԓqmD3{h_כ/Wf;1nZj\`/˧0Me1N$bqLC~O{\pWx?mxv? wT.gJTD<|gX=`e:w:ޱ.Ҿڙ3}wq^X{ߎkw8:Vg;aVB>-߃ ȆHp3x*Ǯ`L*(q{4*D}ZʝZI*=d|w+ 6ދhkOѷ(5ӛEb3ZHKI )' TsE{ä́i)º:vzYa5XNj"k*}9םVZuW獍ذEXͺ"H%(1\ H"PO_zQqu9wpk0)TbG/RPԢ1L$Js K<]$B4mv0"$>#kVbڴڰ252ߝ\5/<`,H8MKTuMaͶq:|OVS/Q{:Ӷ2l` 0` 0` 0ԟ_pzî;ܱk7;*5"z"vE^XvLYC&  qvݾjI& UaX$3knJ=("wRsN>\a:ʘ|rQ{8wu6W5|IٛruJc0vʷ n*də@0Act;M32KŚL,y"F،_7zvMfF^r-;"GdB{s+pj"P ǖŵ~V~Q*KN/gh\_EP{"Nmq2e1 f6W5둊inKvܟRtGe Qp٘80eTC>՗:9%T i߾7I"wyZ_QUޡ*6# {5/&{* nE 5n'Y2@?xA@3[wtϽ^l;tߎӺ6fљ<[O$?R0e9smQcb>z` 0֭uxdC'1fNCbN?N0q~/P˻z7mKʻxdڕ#} . kSjTHN1c&&MAH rzNDMU]ddQdե7O{B]9 ?İUW柡izvpHKp— "%g*Q_U"+tzOiݻy:_>x~I#4vR|V:!Grk6pR4M=Lw[ϓa\jGZ 7:GڢvS(-E^!3ẋ5rZ?= ;mnzLhV?n]E gzN^_r,5}ٻxbM%Pzu\ޟ䋹7'npiFdRO.u/JH6Σza&Z*`dpVrlQ4a(c-]vԢSFm\Uv249{&_sJ5gv7Zp>Eݻ@1|msT5,QW)ZR 47-s{l Y+k]JzW2Y+lga:Z^5w1qڪU] ST90` 0` 0՟)sYjMM4kXƉWlf%,NB%EY7%MQ1OUWedV_[3R.~ֳ/{S'P.V=rŴ{U| D5)TPv vܦ$Rjշ9J q3na5񺻮"+Gnֹn?Aɜ錥tT#9T7OGfQڣVqߋ-O}%Tu%"+9Mt@;BUH a;:j/oHʧq-Ѹs?_WlݢEA@ЈH_SL(5ܧ&1TR^<` 0` 0=xǝQpŲ!0/C#">]-N͛*GHIyc]ܧHUJkz-|%ׇqC6:&$cEB.Ϯ?[87: k=,ܝ<L܈`~~=C}/ Ziv?3?ĬIR"":'zp@a?>&Nzyxy5v!}@s|j8 $-JlWf3vNL_F"壖 @<1N=̬[ڒD(=6mmceq*pg3/&PS3Y)fɤܪ_3MdTʔ`-V9b+UumiKJlR7)h^RIZ6 &ʻv?CmRړ!f `A;[Y&F/5bI 0` 0` 0֟c&1 G0 W?),+V4 &e׆rcܸV)fu\WE띷K7"6[Z/F.fJŲ7."O%EedU|GUI+enTڄ#B)F*Nr)I7%KжOGn=0`":(hfw5 ~z/ݞ&~ߋ՚u~=ȽR2!P)BiJB Rt 6mI^$` 0` 0` 0ԧ({e}Ȫ-`zպ-_*7qM`x~M.꼔1bcދSԨ%ݩ244v3v 2J$1Lt}&~}NPT~%c/%:i3`b%(Q!j{`KS9ݦ=MY$\U?q9\֒+U|=<Ŀ1Ϳyhs` 0` 0`ן 07qOkZ|vלcރjZR-Z*8sMEF#R9N/يu}?]shWzO&26H]h$/6! B1HR0 !nM?/uzF ׻,U-x:\*u)B6:Eǩ"R**UP'wd9YIًUmWbK+ڶm]kH>Y|ѿ{p/MshT)rH;5y)*En2p&I ' =Sm ydђF` 0` 0?џAo~,=)Uf/6Mc|.^ e] $q5cm|{ ƕ[@;eQ.YU4\OgpLWꬖX(I'8nUTq`oPf*85O:f *FW]*sa9Wðb%]T9ITU1G{ =<8ƪR&Qst }76OPaZRt3uE݉×5(l![7Ȋh!;Nu9㙻 j^F xA|p<ӎ|t"]Ɏ.n'WzދI (2lH&bnU,5+ \ݑDN rdg#-j9gp|ȵoYaq]qsÊURr:$ؕc9+UJ)eeQtP2bŜdH Yqۃ6ʘptq/C_xB#Q>_ur"_Yk'; >[,rɟ1G*[ FT8kX~|w{LaZ*E u7o[mozՈ9ݚW%Eб[ tncmiW0rW 6K l[.#զQSRI3-5ZOq#e ċәx.>%s0ʞ#I%fguڪTX@ ~w+)K:ÏapV&2"|^~(zܘӑ An;T:,j6Βq}˹\:r!2gR)b;#bO׼ C` 0` 0`ҟ ۠p"Jw儌Cg cPMO0dLȨ(?/mR{NjzD:zD*I)%-;G)w:M8[!ڠ 7[bܟt}}X*+\Uj'r0NVoٙl zcb68C)tvͫ˖xݹiZ(װ?:{nѴxY"HlGHIJ> M^,"Ce$i,Ы Os-pg1&'/y8y ;iZNPe"ʿm^jS{tuIbE=V׽w!"VI+gy{o(~3,D(=-Gj+$ع_N]Ge( &+YVY3wSYTQ)` Q > ?P@p C3vn顤LzvJ^6:XEl(Q8&^4o&_Mkgn«(l {z&%W 6[hMt)D2:*yvĻV$y$As Y%΁`RP3w>]6sU5;D{NQ [9ߒ<̃W9 C"4Z~Ght>=^Ӷoo δZ#:-I" pJRc%:;F?Z'#lW ,ZAMRov(JT"198GcYtu*sznfeZ@M=%e6;VE4F-ET/wRujQYot-%&:e$)#x0k< |jNJ]d'BRAY|+H/b##"ďb+ KwVҵ$ê+><`Nag4(geM ޼peNlжc¹/c9 C{LrY"X> /%XY.V^f` &(t]ku"+圪梩NZi<@0T51U?g>sorɩRe_l޳3vzcK9dY4HG~wG+.JrN2᢯u|ceb2WWEO)L:sABm _KhHT+6PЯ1"*@讛^IqDHu/&Iv螾 zM \rNjuV~Jwߋ\jBtUHe6a%' R٫L!S6i|zxg x}w"6|ʣ\E|'z Ŧ6<˳x*nBR "R3ûf8+Ə[~j&*+ZsqVo]illRi\))c`] S@5lݱ?zی驵z+n)C~ XbpMV2]1PD*o[4P! J=J?pI3۔UźIf.bn"EVo[E9"NסN^*19Ls(O!z@<|<>ܩSvNg,M\(˳Y6UQ)Ld 9D@CD`ܣ"ټw mX5hVXي YWnp>YHSu«*m)&/VL. :oKu>@|L,^*Q! iT ׆WMJPªf0(x|L>Rhޡ{oshTxxvU9 Wz$]7Uc'릓&ˆmpś:~x0矇nR`z8>g]-7垯2dg-03ԏb_B-ƾ\:&T1˜M:=e1 VRњpy[a/.zL٧&"vS!]17C"*9umRğ2xアrї =w\0O1Fe6Eޖ(v)#CCAyIUu|$3c.(߳n+/t,^lo3?N%V>/ܷ|YKo!8Zi$UoJ- RRނ1G mvǰY"P#|.S[27W24\ D'oabHIzTn4YX7u_oqsbb=.dYil6W]ۗ3gmVl,"p 4h&S'(g>ݢWғ'[\1Z(% BHR5s,FMnշɦeTP;sS"y g`0` 0` 0ԟ|ηqO^dA]6ņ,Hd3?N4Uf]1*gT(S2,pqo}]ڎ{eO^kC/NZyIMz,/ geL `c N.M)yizrV7%ug|o2k}1%Ρ)ԫob1{l5w[F{BAHu* lseiR%6Vj.:!viP;-)\rʩjOLܧ X%og:jQw=c5^lu9ǚFP3uV`r:J t!?N!vXIU{f\T]P` 02J hTR-/՘V1aP[>RAzV8BE nQT< IVjFR:$њJ,=˨Fɨ,)7QzP7|}"Fj-t|'7wTo+ F-g;2bPJ%XbNʏ&]~iKVǦ KVu ^cl 6BvdyT*f!P s†5NW!j*%~r'UVG!Ҧ3Dɦj5C58&T\B1$a:)z>9V*E:#œ)&z4:)(eP!TQ̛&1hA~UF-Bڤ I \soŶy(khejFpvCg,UƼvʉ;EC VP15^FOgPNo5Ip>U~d V5˅)BS:ج_ɅWui=ӣ=}ej2c% uP)<P Y>w6=t? pD8wQ%v҄ŷ֑uzB ْO9JCs{ +͕3OXOi?@?E:7C1nuEl_vZ6ߴ]-/ `ǧN?fi+_kfLvU9K6Mv4/N\#V ߴ0n9ו.dʞVm|#^/v)@ RJP)@>06`9e۫궱35%CҨ=ڹ;!9۷_v'eEڣl36ZWcs&ӿ5e@'7w˙S~cRhԦz(JBQ^}kv,9eUt/Ez_GSTj(yf;:r _#߳TԤO{F#QrRgV_T\CdU9LT4W'Q(=(QaͱqǞ5Z@L" ""#DDDzfKt,'̓(0n%W ěNfi8cs?omqi+_yxch*Et`/i|e^.ce R#ݷ ZTKmpT)u>~*h\e  a &L"}~[$U0mگ2Uc=v=標1nf]fו0ƷX#idL*e) fun\*0` 0,sfFxl؞Z ' Rt,]C}z}>n<$m/Un6F+nS]ȽBP3Q1L"jAJ ɂPt8r#@#$'95t|zrIhw[$͑-]=xx4V5?hf@ӣewf<0` 0` 0֟`meeX<|hֱZ;mvs%UEL-!(UHQHrJ3&9_}KnYjO!4 bUJ$ 9ڠAf$嚝Y$bS&NX9tQn-5G4;ݸ#3m*x&WRm+5>Š@[h|N}0xJ7wYhIMgLLC48>EMQ\RjZa~͵88:::}}w3;z*]Y$6)9"ߝX|0m =5[+mhZxUi-42ydAEOy%\K2Ll{SEBučN9H2ހ't$٢/TJ`Y Z`hs%>RAs{npQ0>Df3=t1W3fdp,}:& [c߈ ?!Z|o3-i5z䥢[?vⳒAM'#pp(~ g1ZyIw혘q˖Zx~JmFؚ.F\]n2dZN %*tPD AM.9O2o7"T}]{nubPK^vުyɟpFapwGU4X8~j7a  @=:P4#`5Y?0 ~3nʞ>C<ѩdHxZQy9:2i:5ߐ>_)i'aˈ)7}\1-1ն qEAMœOFrÚ~-mDZYd\(o%-v,!La rw^Dktѽw7'916,[,1MԓPt=(Uݶ8*NQ#/M凐Hl&ܷq:8?C0vJܢ6꽣Qݺ_nJ 6:~t<5 V%z3zN<7 ^ӮtWczݻ$^s]+7'jkދiPeeNXvj>H?'3oէKɋ^NݘfIf﫽=H X1ç (tݓ}&$ֲgEYfMWHߴz6 7umxb{V7G<<C7lo|Ҏ%e^e1%>N\>F` 0` 0k_2ؾ&N!Sx}Wzb?g_'%8%5_Gwu%}_ϑsZ5k; dgz³sU5Nc,.̓XJ2@@n!sqv֊nv,)]_9`@^g[T.uc;]4r+S;;:lR(&R=e_zF$28` 0` 0ПMsQo)R͞%^ .XwiGE+RX ?C G*Qq6Ua79n8Օǧ1jNGHvN@#z M _ʁ;~ΰv^-gc13gQsҩ|+>ÀYӕMqߎEGO_O) a(gs:ihRȳcޤo'y?wPQ0z67߰g5oREJ:F}] o5QNGWePXƨ]5D}2a bүf}RGO*WZmRǝp^gieQzȊzJ9t" WR te &B<a}1Tڤecc$S;i3`)JB bv9J[}gZIC>JIQ Zr9'b22-  e۟_rQ0Ij߱iBQnKII{S5e{k-ky>=mؾdNȪn DSj&d4:c$TyA7L2Am& Rߡ4 Š'U,LYussU9k 4^=dP@v@a2`&|%" ec+oIS.vĢׂ͇M@SH&rb_8@mV]-MvV[δŢ*D$`rE<7$$)ygfk6ױYG+lDsJf0` 0`Tq2D902dM Ye{HrR~՘R?O!nٵrETWtUӕx*T(3F I/2!R5{^=^$9{ɖfr˽NMfI9s&v tHCyr/I6'7TԔúfכzR$ԷvGz^n@>kWk[d.=LΑ u)Ǧ"._zS` 0` 0` ҟo\Щr׎۬t ܺ@NTw9]s`pͤwlEщۀ4[*lN3P-֧xUȝ?Q/i`UWD) 11b'%(wc)ے8v.ÖqRzu?oJ䄭Do&6`[ȶp ٶZRQ`U2 )snۅD*50.8y'ڪ ⇼63{#[kSvGPWf4^d]1p`bt0Uaݵ \Ȍn򪧥oyvV+\Zvh`{ Xd⥘3`NIFI6I|h:dU%Ha" QJI5֚n/,ׂTs V&%I[[N۱Pn2VsSD.:bp =lVr.ڗ\]jߕy&{.3? pTKȫRpׄ|zqU:Uya UV,6 H1@ۢ@cmm؍mŷų_s.ܧ3\\]J$)0 %GPq%Jp^nP/SDlƩH|m|V:,D]a ^LI#`" Kݨ2߅.ȷ knwdnS}ZMܒVa/,DmW[j~Ќ+suJn* \Mt4tWzݟ`YG_m V+'='%].Y`@ avV)P1z=|{sVm,NoMVyǪiVf{`zUV^vȃmՁ> āٮՋk(?Բ9+4%)Ƕvd3u P{?ɑc^n>~nYw}9C%9cٟk?ew#t siw>'>iw5gf`TvEUvJ4$ mՑs(1kY 2*=DEbűQILX3"mI^ߦm^+sFkUZygaq[u[xx*F_9cTuU9=ʨ"aJ>s*]k*y?N&M0n6uu/4[+ =Z@{6J g,ɻIAOڝR&YD 3/J2M!)yL[SZmh'qFW[ܨpPvI uɋWYx8+w e:*<̦ y+mUZhznx\ʎ׊Ҟ&1g$w5AՌPDZ*GR|vr~|WkOj>՟V<5rV u;+tȭKkw+H< k['k5Nn) ѩN͂%zNbTD_uF4fq=*^eSXqsimv4!4|/YS*=[*U˥qRe0` [<]\Fhl|ԤDN9Mx&U̲dt W22?*?-2zj'eS&w=5e!Tg %a)1:n rP(--rsޣܫeϰ'b̢7, Q[$jLczUf䣓O ȎfT,(EŔ+f2^[:r뷒/9}! w2/T2^zE\vS UC0DG1nՙZ%vM}Imk[\k;\W FJZU [& 7*ݪJ)8STL0U6{=mrk\rl@^7FRJRp%5VFv# in1c[ R(C-LiTKBYX,0` 0` 0ԟ>^W?Z^Sjst*:cZVY &UQ5H)" 짫"liu՞X_^ɯrZU&R=~ɳv?sht>7@c+gް2o6EYPn.c&(>d|(t=Ӯn6v̫JNORuӵSܙR$͞t1IJVX1Svczp(5Wv,#ԡп[:d78ڹ$s;wzlRꯦ=Ykᬍ5i/kNQ}>(NQ0tuC"%TFLHŻq3"DxD\RU2 bSta27wOp42Xb,+ [}IJfq}VS1L$l6ʜ2};ۋo{`ps_ o_01jFn}G70r p$hh+DbFXJ)=AK֣?էAwq_y|`9iNXZ<ŕujj5nA].eg7?"!JH:vq"FrP.n7QAC&Np]qy,{ɪhu3Ө6fx& ȏZ:PQ%ȀvC(d98q5ZiZٶo[Yӱbq/mL+ZtkizR5v5kl'ܦh++~$0&~a%qk.$W@GT 2bRC `V0ԏ4EU7i79U1Q J!|U5"ERPtL:jԧ!"S=@@zIDI1F %`"v n!נ'&?yD?ٳ-}XƗOk7<_k~ UھZf2j<{@ݫ aIE:yUUHSd&%Mqw:ܢ'6.ɷ Vőr2Vbs.U׍4)W"/ՏB]F嬠:R|{1*bTs~7?z>Pj;Wy]rIPY7W->=ӻV poi)鬸%D5mǃ!mh$8oPD?zח @2,S*  AFZµ7F)fOeeM/vWd5^>e` 0` 0` ՟c5R7ؼd ;{YҤֳ)UT6fP p2,~# ^r(u9G.R[EXr:*M)pPZ f3۷9΀䇚"+Ov{ф\mګ5GStRCiɧ=tUܴ]*ݯy*(=P'`Vsћ9Ae)ҵMN /D}vƆc:Sʦ?C7iGMFRr%^jke`J1;SWz&osTKH;Ň3VΑL jA7G~jA^8|G%;<~ٍ5+Q]O^Ҟ{lD_ƹNԦ"n2QâJ34\ N'#3>T;SJq,G5vMO>>R[W%"jQ^ORD#YR:Ee:WJe}v\˿aaJbBkO[Ħ4EcM~ƶx&ܧ 3cecGA{Ӟ$+;N7bBA<1Py:M9z`fp РlQU-^J3oHH9:BUzP[@ʐ&낊VE~oF>I: g5H-tv \򇓍$[rK(zONvOR/OӢk(OzaTHptUX"^ͣ:kFϽ]vU=l]Y^#' F r@$2U$#(JBMӸJP7Opu88EIܬtYTu+tS8ƴp>bb!s[Ffy;鏋b)+!mQ*U3pvs;v[V)? t׼N@޷vqZ;~#CAYeW;q0"P1Cάj:Ojv+#e+#^KiAz>r7 Qi|tj%OڕdO{3Y'aj-a^ƴ 0mrs8UYt\IEp具,]4'uFIۧAFOWdѻVB̕*R7Uky&̮G`*"%xȲ`" ՓMf[JB)J3ׯd߽vW2nIsr\'VnNjջس"cb$Iv$[26Z3ۻd'`oZGҤVYDW5u,âć'"!&Lv}U׽),I^ƞeފnJwe*ʠ7V]o1zG1w8om/'#߰b=8 6kRJYRk{Lv4,ג] ,TO]*vͨ1` 0` 0֟ ajgtG4"`k2'#blb KUu bu0f }אKٿlѻoneřb eI6|B̾g)72iT.W(d|.V(NNI؟eI|g?~dWPW({eq~nᘻE1w$N=+骟y C3# 33lʷͅynZ̜eIE*ŴN>^.6},XN*QtiUN&ӄd:&eB)ߑ"$ g$QrgYqxt%)Iv OmطomϙVQnJn-4_WR?rwg>y]"ҥkT,(Tc[yj+FǢ]XZjq,b2mJ9EרI3y^u^i?#]QZJpqrW"uP 'L^{.fV>}$5r|c '%e.d|mu*JuP>3vtAۑU(EW;>_nsQG;:Ou+ϫK5 59~.*k_V={xR tCYxcY 2>l׶ș81cݜEէ=;ĵo)ޗ*診ҶҰ2԰܍_,ɵJѹڢn22LO9K!QU.,1_9K&0>MA!y}zw> ݽD3$NG_ +̨{DʜԄHPn␀cPxo7&]VIUM@.qǍ=X|9,D P9VIu))b@wNv ۷YZσ(>%ޤ֛,3˹%˗I;2\g< 4XYKDwJ4Ihr83Hp)÷=[uJW~ jZjR} ְW;NԚU{8ONB_lnjmPɍr?Ƕj< S9jW@˶y-0Nbϔ'S@çq!.ru巉Kh*Zi] Xu܎L8jr^(']\|ݗu/E%rEvethhHM 5YiIGT"r-)D刀vy'xT=\9]7#F1J;ro_yiI?n/"#S;77tʹ]͛]M)6?1pqƊE/f10|Q7uÃ;Y1 "Њ*/kʺ)AT S Dz;JK+iSmV4jo]jz#0Ov%FZ:۹Z;45_7<G~mʘ` 0` 0` ן†j֓]kYܰfod=;r)&􇪬%T )N'2l/uU8y]Y,oOY"+&zV$UHTLt1Ne>spsfleVr]V;\8QU5;\;gr/c\#'9F~H^:K?=ϱ` (h.t財zE>NH~3|٬BFhk%ȶA' ' T EP8N∀\;%bʩ-UzSB-)*5$Q[#S$vvI2DCX k9z\#S>뫊J}g4گqtJAM$-Ui-*gHe*-1P *(a#s(q@ x>_Eh.?>ͷ])W'/꯰8<hWT4Wc.İ|ʨ BMbTj/NͅU,Zܜ%']"iFyhmt eRdRjunPN/S} Hj x+\tqԪ}iǻya?]՛*z%KJmҚpsWiDF4>4NV;$w @2Nm_IӨ23Jxgu? ôL}"A&2j187}Qʞe޸E5%5*[PNE(fU fq-J2UYɹ5^)IU4eBq3UB(b<"q6H( GJ8 -(HzRݥ~:sT\iM!(^.umeѝ%_0|k]d{pZ$r.5qV}Mw5@֒5JXH'*$I 黔lR8?rI4u8@,nq{Ď9+o*6M6Tn-HtMm!%v%Z&U5z*'{U6FPW\ԄC*V;L/8*:[u0G%+n4óMJԲ.yQ"ȷ[){SV2VeIWD'D2 SS"_ ^fv}%s>]Բֲ]+%MٳҧQ)ظ!R<3,_JE{W/,=l\#ڙD QvNջVܮ>Ī.FI(.V( s|D~L1N" ;ttYE7>yw% k] ڷM*/_w6t'IC u}zft:VGf,ꗖaHƓ0x~uޕJ/oڎ‘Zkc*x?>CSV)fYtj50\P!WRXCDZBpGv %o|$?FmmKާ}:na`>ڋI{4i"ԒsLcü4a;(!T)Yu>2nmN4|Ftp/җMW_43t\֥UN짉׾(o7#}tƧFöS~dӖ;^ȾMz_-hi@T)z[#2(` 0` 0`ПߔUcY=m7huԐ:ݷxN)%eGВWiFʷPʝ5X NReRr{x(S%XidB-f6ue&P tVpd<2d8uP-+c4ڌ9lo-$#^\ջތa sEܫr\^kπ` UorD ETzFQ6 v Oxtܝ-Z|9U NFbNNs];$f@E#d(g-W:U5inw2#riVxo[JF=)nJHJDJD$TQTEV} #[Vu뷬F/[UjNV>gq-۷vW+n|_}%ʝ  ̳=zc;Dsmҭ~J^OMJ^zSb)Ӭ;d'Oڹ2wWK(燻/=?,zϗWNo ްW Ios_L:N=:}z(g{VO՟}֟K:t}_e/qf~kic/Q?AS tkr$x{'$K[E??~!}tř_y{izW}Cn<>Νˋ?[;y{v/o>J-@~gFv\])kf^s>r\waSЏK:O [*GO|Y3tʕG M?PHF>0}3s?^d|Z1!`;*`!,ݸ،<_;5o^ӽuʝ==G=E0{)Vn#["̓ː0tSCze߷+W`nJ3e8J3&6-5ZMXҘƹ pfs|M(s][~\'[/XIߖ|0 aCJ3j՝ /[VZ )}ð;BƦ ^Ө_ʆU}sFm]ۓv[kJ ѐKKʙ|Gl eAu/~LIbOLv.Hՙi~r>D#޲f&-dG76(LQ0` 0` 0?џ?>yw,ɵ#E洊2 Au`V@(rr7$"49/A1LcQvqNZX犇VwQ&9ذ^At)&)S(?uFf.Unɻpr(ޤ#7)4V9`lqsr˷cy%ϕ6ZKCx~N>?3Q0+E] b ܚ $5 %2dSA(뛭Yc[V5;&X0t<>># Cw #J>rW,` 0` 0@hq)AHPMEР7͖CB(؆0Lu=,Ki{\ oڍNT_md/.x2Hkґi&TCGSST~sg@}FFfzuo'1P'ۑc݅gn&z*6.#FX'Y໣.x.Ȣ-aՌF~OK!vpL?hH =>rC Wz *=>Bҟմʟuա&Iͫ.IK=?3+*2Ӛ0ϱ9ұ=o667ě_ սzf?-͗O^VX6nٶn21 =UQrVExx,RU"dXv@'Bs糬X5_>烛ݪʱִ1jըr̴Dž;=߁f"ܳd˔$ڰ#9&#ɬ*4/%y;7Q/ʴ:#.i4ٴ㑧vԮnܷ<~id6E($\,8Ui U*Vs672{t\r=nyVە"M-t鿬Ӽ|\hf!zs%KVpN)]5sIZזjn x,pXB Lt>Nոν3iʊu[b_"4Q俵68}҂j$a)D騰ڲݱʳ\I`<7P,YDZfcI%ND)y嫓m[nq|l쏻\N[a&XV%hӌ5Ӆ<G *䵇t奖)[Nv9oב31` 0` 0ӟn|pzMjuGY3~v:jzՙ<ԋC̵"~. eW>@ێ1I*;6ČYV^O ?p:H:wVCQLH?xeSkT)ljӮzak׺~ 9]r.H*QXy.tPJadc|ޔ[/;jjpr]J..EŤRTfi^ءvϽعB$2TjVpkFHT{#N S$+^5$IMS$V,QF|Xx1ǽWpWv ;jZ6;fE{$<@᪀Ep9WjbT="Ș*7@zqjz%^^EW JvyyU`6k\ϣ\~F%*8bfA'qDP1}%mXs-څmqtNJ\Rk{7Pn]۷R:W%I5(&I\2{9}MUV-QtBɪZUZmH4bh,-N ?,0W37 ]roی9Ԣ_#uz+sÿRiғ\]$iGřj|4ƬK8 ,$VؖdYٯDFxbrk/[* ,s[)==@ST;RЏqnߎ6-˱J/EIj(S*Hm}Z+ٕۜ˖-v:VU~kĺ /i1i !/+HZIQ}cb*bAvF~}A+Wz_&toZJAÇ Y9pًto-$Xsk7rmH@xBHYIed1^!?Y.>bZ8yTiM:m]?~F^Ay*cT6I;dY#5wq Ų&tWIʘOz=̨twɌSu$"Ҕ^)jJۿyo1.E]Zm%NoEJb}=&",rʈͅUL^b")$+S< ŲC@Pw~}Dw{wcU+r`$״BŽPo1qRek ͚b6#:8;kWk.ʔn0~E%wny;1\wT.jԥIC)-yd͕-ڷbښȯv\8|~%ڕQJ_3~MlmF7V\r$fuA(B#vdOS)}wtvZ缕t,}6ZUk_A=7{SWJZqz֋hD†bw)Q9XW֑X-MHS%u r{|@6ߩ J2e/O~΋oo1E 8|lHvfv"֜85 WGo4z@I= Ģ.1OkJ\zvpx?-ŸΕv)ۆ>sٖ W~نgl,.Rgf-3GHVs$$y `)M+ cw݊&vkYPkUGML+VzJ8ҿ eu7n\FKo{غVV6i!Eՠ~_s)gb;kl/gw'&̼+xН#9NOGN*tisNř"wqZǙSZEu;Y&u +5=yvבq.,Wb@R1@QEP0\1~T\%xܫ|{<W֌\tמKӉe4_{T-FʮPlK# xvZ!vܭl)%9@ Q btMUatTӪZKoyⷌS[z>:sP ve;9JCv\ERM3wܴ^jd.1ܶLD8A3RT!=@<0)^?8^fζZa2Izκ۴%/w+XbUe[3"&ұi/;q1rs1Uo]Iv7In{y{4m]ێdw%XB~f8+R02s@TzglUe ze"Ic+jr ъSU0Io:@٣1F` 0` 0ԟߓKw["*2ֺ(1=,E.jǻn &?71̻_;cև?vdc$])(eQ Ν$@K Bo:~|F~^N&D` b%1Sb >p lrKܸx[Ɛnn]z9PR}$GPNQ>㉵;VR|efc5uKUy) mpkU5X%qd[)bɳU-cm«$ɱy%7\[P^~߬-e[q]Sĥ/ھkimM+Yn2%TfHqa/!ud!@ZO<.W?W=o;s>fBk8fktR9 V+woksD2HUPg \D;߈:X.Ke> ٿg"<.G:lMSc~miM@s8@n#FEQхe ݅0j\UiGJJ_3|8$8ADC>\=e#uTTs:REG UC̥HLɘ% Q?|EpQD/zM2P!z; GT ("HUr!QHc.= 0HM[hբo4ģJ?Z2%mb9yU?PTDxw}sܭ݊ ( a8.)4SHpPEI (* ':b`(xu2!!N!P1(SFTS@?@Bָc_7d]WY& >^,aG8m d(O8'^ˑ~\f‰~yESZпE26qBb43L`[V>/06͐fǠ3겹ݰE+pBCyfQt~+%K1'忂ո_`2țkj&|yJ;.έڧɹS!Mٷ3j*W%v͆= .T]VWɧ~^$wls}{{]15W#I싅" ݋vkhqiIDE)ye V6O˧m{7!"K/^%Zm'Z*J:38j"-ݺu- !! YU@"# #)Lɝ%Pw<.E%jQ/m)Nsy4"C` 0mT]qWmFUۍfRrj$uR? )D1@lS(f̊"E1#z-JvAI֞1f^U/*R9X;nS 16vHȵ"|Pݤ((n׬ڿKԡKVܳ.{Sqz6n#Z寙jGtƷMqTŵE$AkpȰh<%xD *-pRo܍) ;3Huhdo>b/&ɑ3BƧ)S(f2F Mr6BP,9_}oRg5rY3^4-}}"yO}l|y6I6 |2Xdu<% jjB4g7?Wf^֑`4o1LFE2$QfL "={z1-oW'Ov%'m/+U} .[9fVYΊj9 @|C9\$_FQԗc=9JSVkUR@oŭ{ܢضfsL֥tdT n1n_պ>9_~SW1qVʗ_?K4HH)J^}v]"cIH(J!2.߁Nr ` 0` 0`ן/EOu8([2kUfhACN TH?7A/cᗔ#eYJYd,ײsljڱ\/b;3ź 9 Y7E=SDZ*]bE)1; ښ/i?=WX]]&낧`Q1Y%]l:cUk w_DvӞ%ROwz"pU"b]@n` 0` Zy("蜊>VԢv~VmOd]ŗoTgo"+I*?* $` ()oC\<"ڞ0fgBu[bæح=h2TU2RcH۷t斾dHy~)^Xf=/me`D{0vuJ XɴrAS# ztTH 1` 0` 0Пo-:Avƍ`֎G]t^vB56@G]2n5*pFeY+Q-Uj˛2k[ad=u WmV d 饅)"*B%7YNF.L|)xQ|>h&\I3LqR~ut [; ¤ErUZsUTLrd)tDݫ7.%bߡ,^mU%`]vǴ5^߰3/m6lMKK(g{NQTHB4L) s7rNp ;m?|o]zx_%&KfݫHIbf7Um DXzנ K̬ڞRa\sRf%Jĥ2ܷ,aI'P*L0[ߞqqyw(+ 5%n!G/:Ke=r"bO^TqF H }dmmC׿/5h*^PQeSP`oyV7}J)N`츷`&x~NMjeGn2v:s 6gE#{-ŋ9) -(+\#@NwUPQDSf/s-N<~R}-M Ύ=hiv̽}<!$` 0URA%W]DEΪ*rI&Q:(ĤM2DD@$\ds)xY2My) (OZ(gM tbֶך#zwn%n<->wRdȏc(EEUNR1s|.s;&i==!~Ja6;HMѮiù^=%X.͢ٴYpU{v3F^x:7J{WM핥>N-23jJUҎqGFv5URbg0BQlm}o5dxFqy>r~Hꬩe1R%]p6r!F쪽ҕz6u"J>PI̤9ݹV34e  AtoT@or#ٶ.Wnqy~v-JʿJ0~*0,-cI  ֊zޱ\vFIC)eD \e\kP]5旱i$n!7lJ77m(R-UJAdæU2?XPHCgYUUܽN]uôЗIu"!"#sx>Q[rͫ"g/-)ǽxBD~Ne,7`@!D~6FG?ȴʪ{ {61><RnF_$V&0Y^Aݖ pic8OXI5uz$k?(gTZOS2uT"u tJ6 HG.h$J *OJsVݥ/ݷZx卿vTxzM9C` 0>$TK>?YGn+nJYy"\7B1j"dPެ-f+Լg&v'lsZ5T9r%D4Œ xF&< +F1$j.N# i|,ovQuj\VO l 9##AWRX+V*0@#SQO!g1ˀ{ztmciUKO1{'a7Ej5Km 0B¼ܽx?=8xϱFbhI ,6yN( c%x*GL]/SKMYmM?KS*DyhxuSRgQGdˋsQ(CpddiƹaFi=ͪjrLk %E`mk0j#bڒ *Ku|WZ 9ç6khFD!cg!XKOOF'#-+R],xF9U\c -^v=c|ު[H*7M]}^/k 溪M$J5`n9"EN1Nu \j/'#foNw: dȳb}]6y Fq`4E܉ɵ|[@ Q-??l6^#)w+Zj D-]VJ;iJncAAyF2'Uݛ|[-zAutM?.:nA;EL?@[ Umŗx;yZKG\=^€dҌ?)Kµ , IP.r9 C(b%)DDIOJKOA&rV:jZ\ToiK]Lu;W-mP5zj]QC֍i$ ''F YS` 0` 0` 0ӟ?v|{vV?ظA$2٧-39p u2r>,6889҄^Ʈu=1& aT[e!MT!r@@Ch\Jov$t5WQm7,չIĹ|r_wcqWbҋ'JNRY{X$<)E~C.|/r&%00 $*K{B6G []qdJmDD;#'=yaӧQTR߰qY:ĆLN!D>%:g;' S9BaD"#(QpTLP1a1?2 b=@UP_ő'dIqWנO[EThh6z j.V\ |`0` 0` 0dN@'W>ЁoVzx `ϓ+u=*Kq2e/?YNhaNةMΠH_;8hq4(Y}UgW>wU^~]A}9A*zI/O)*URO Y*R"ޝ!Z6dJv!܋/2TSM$7!#kvT` 0` 0` ՟vc;z(?J'fm$M*u%)QX:^OJ+*_᧙}2xdʮkNdDAyW=!V$MI@h-.ͤLx+0ʒ«e $1O&n8\T%/c%, ֎qf@A/@~/B?`xٜS=x RuO_mJ=FݚyifsfkUٿj)㹕 LDeaG:NMEA2\Mv,+M*?=K7aa6V8+4s&sJ-}WѲsGL]`Q@"KE+9\S]t+߫,`.|[Jk_2A&\\Q=gqeSe8U˷*Oέ2:jӕA=]a "ǻėTbi{{^im3v_1u}odV6V]In`lR>rwY&P D0{VTt/PmKPOHl^Tj 2[;*3ziXZ'i5S-5Z3`GΟp.{uĶ%'g)$K2-bޥFu:.|{DUp ɲ)A1rtHn}nkp{k_( b3k`5o?'e4e#U29: U|Y[U_3Rq]JLH1b^;Am(WQ&H1`)@:QKʷ ~ih]̖Ϥt$q dAŔ\ $? ゴ}G786.o{Ц.\]~%,7HxD}LA`0.UE $o|"L'*xe( B?7=,˳\#o F4-[R:ə{uw2o0Ν27QN&u}efUIR~v"eO-2 ;k*iz}^s7 hZ!SL:2JP*/,+jʶ ZX_3ߖ$\;z Roc=/Xo${oBn]@Y`&Xd雐"䭝%zN٫&n'Czܭ܊pjw'jqnTuL^<[};҈:j{sc= kV& :Ii9]j 9a(sƿv(y{b|2UwIK7˖Ӷn?_LE,-`l%!٬P"^(b(e_# uRܚzTs}Z*J&..]YGPEV(*c+O{ŗre7þkbc#YFX:Wh?Z2(ܨ*Q*SZ` k{b+ֿrmV"y5jptkEќb()V^4ۓ$Bt&1`%gzvwt7Id5z֩H`unq2IԼB#/؂%r=Vjgf@LQR?7n`nqʎz| ;\دOq5{Sxq@zzz>ŷVLP9iGF֕ 8جmށ.ɢ֦$1P*b :rʺ֍ڲ/57{ \䜎 {jK ڂ)KaJxFlDT}-&ȝS w*HiN}d`.\rUO_I > !#?DMӸ@~ށ_Gq 3bKXe5F 8+ 7L٦!r?!y#^k8ݭǭMƭHm*,jJI(҇D.C,H s92dlE*c,nu2EIUZtBQZ0Qts5|@YMlBoK9*ͫ*ųAR6gM%OʼoL@qvY %* T.۶­_LZ5*NoOTp{LLӶ䗨*Jq PqrTe̸NYj%v/DhQe]1v0+ ;Tuf9rL4y^?Ep[ܴ>$rSa6P 4.v e=D0+*Q%c8%o5Sm)o,݇.r+|}Вi * "P\ɲ`UT * H.,ɎEk˸K@΃GC]r?3R$)T0)0n1 n-~WLRIm.4[ ;8^ҜQ^dM=htrޤ_?a);'^:I]2ј hwr[e^B ,' uJp 66LQ0` 0` 0?П{q]@v9:o*ߡ^|R͞mċ3Spi0A0!CD8ҌʳNWS ˍ敨}uF<pFw,ՆBUS=*}nBVJ $JWrnU.ak4roВIdj,.חedRAƥhDMP7Ec]*H&@⊆MB@<jۗ$3չsQiŊK kq5eV" UDڥbDuY8 T100 iTuZzC>O𫞝WNrC-V|u&ѓ7یۡw?rdg [HɜH&ȃf$7gp-c۪\_{f/&yw~z7ܻ̣{*vؖ٘ʰEz%7 `KNܨaF%O_쉸S?@Tn@*"#؟w^:FAlKj>=n, [VC2pW4ȶʔR79 yPM4jc^5Ux,0` 0`o?l~#x~gE؈fSNC|yߴ빖X!*iU6P{D' ӹ24fKq0cw^]'mb*:R^NY&rW7(_ 5׹8cxdz_k׋ lD(y$!T+ucF)O*b0` 0` 0џϕ&&>jx]-w`xj^ОYRh5c{gvɟ?!tٞ~ oQ!絍&(vDW!@ t䃧n8ߴBx=-ٻ:zVM&$P` 0OUsGfGRMt ZFRsqq{듺RaUʼsMbg1̡'U}g^53C"eݻHWU\b%jJj來HTm00ص+UD.d˽6EifEVQ@CԳjt|5ܦjf돭:M[(>w$Fɢ"P(yp9C(--̏mG|S+ob=q ,%$rQ#'¡d{HZW"&2x< 0` 0[NA9ѰcD+#E2D$>Qe (=>n^/X?̕\؊ m{wZ$c`^R`@lSҕb3#H07W~mʘ` 0` 0` ӟU׹uܛ.T[I.b,ƩW*fudS`P*=Dzg~SZ`FecLYIKfnW4!8L[L`8&"ȷ{*Iʗ 'P|h_L%X` 0pZZMz^~M"NIǿMV8$麯c*A#:G"E#Hv_ OwFе Һad^е)7(ϭ`,K+5ՊЬ+UN0V 4`&Zdբ)nDq*HR& #w%>{Q'GSDpH mVtT;|̌3hbF&c&s$\+dmS ` 0` 0` 0ԟϕ9c N6iTzg GF"ڊ,z.')JO1nrʳy*^&7S3 m(17Ȃh:Q0OI,ѧ~ƍFmNF~̉ 0.[%z~â"FYxKڍ܅⽌0` 0` 0a w[IGoNowK:냉D;1S/'ycb:M}]?|a8H ?PlMWEbK@!}Biv+kvú]He~m_lgfdy~tlؘOXci ,lc4g(}o!i,Rmd]'^@Z` GD WKD|t ˵2z-!%vm-}5:ŮRWݞ$ʳtt X=c^js$ CC@lʘ` 0` 0` ֟?Ľ7CKՎ L?YJuB̧1bq"{_@|AC.9v񿹵MҤnJ e888&mMz'bDV@0!kp/l ` VMɹ.G=vdh~)EŒ^Ѵ%LGڋa&` 0` 0`UR_U|{NW]LJ7E75L۾4"f fkϭ~yFqcrKG|D#t` cۘ{WTbv+YmW~x|OB+p"جŘqQH;WVz?AQ|4h<ż0` 0` 0ןaD-lFN..aCe+F뢑&o8q ?cP%eX猽Ӹ ۼrmh牳v@#wWy%TC(fԱe;OoWF|0F ^߹X"wq5{y:f22K` 0` 0JdYJMTUP1N"S=@@D`uKTjVG5ll. rݕ3$ғf֚>F/,N=ͭMSP1GI2+ʢ`1~u$A8zb_@r 7HOlj+4*~{ꄢgƩ֎ !BASEVv%HEtȻ) tl| ו1` 0` 0ПnTvua]yҤh$XC3TN*uE~H UA0rʲ,:6B88RRv,EJm7.,HeUH5#r&7yYN!TgJJ;ÊsvO-M9Z]Fi? ;xrrJ0] ܒ"ܟb5u-SJ;F&Je`]l21ꪈ:dER7jNPv+ڵB廖݃cї["HzV]D)h70@)f8lʯȿ]ڕZcEWkdS+JŠj7j=NOVed"x}IXHKGGvᔔcܜ񱑬Q I&,$eUS4(82R2n54xVmbc%8h*7H(Sf1CD` 0G QU]ts%!riu `2Mq#{ rNR2fP `0q)N8݇>=<4}nW=okn} l8֤[ɦ"bN6a Аaʨ&W*:8PUW_&vk#b(K%]*"qRU;`t5@PAD:"MIeLrwG^>\t ؈*^Q|_Ȫ~7'.x&RU7.*!TAx >D"g7hT6֎ԙln/)=T_-k3(31O]rTMO?$T8܁+%0:7Aӣgwf|0` 0` 0џOڋv`-/O{hY9G*&N%*ZH6AAЅtFU::`]E(̻+(HG~_ ; ?a~(kWaW'7'1Fm`Qh3^`aݶZXbDŽ2;$ZEs^{ddʿn$]W'{u{Xgb9|[tR9k^oۙywzߐ5j%K^u3]cmҸOe"jKƹrdAs9Jز%o-XsOJTZp֔׶JWmI9b.u-! #Eс(ILm{${hJVO5+\4DDǨH|3M~[=mܗ|I/žqo>r =~RKw{Xrl-_jIݭ2ʁr *xdH`9EJԌ"j1q5(WvpZ6:.1flU[|fdnBreA5 zb@[N5KTl+w,u˶C W\4Fby5zew4Rz`|ݓ`9:! !S1ri# ^;'`rC_mm^7m_jw+5 P[rq}mog.FE5Io&G3f!AQre|k|&e:@~V2u] oeYezk"զbS (9Y@"FILMۨ5^3sIpQ){n6Q&jFrdMpIUJnӘE#G|ۼy-x }q"z㒚T6Ikk9R uYlNi$vDA4Fe7IJocC?{:b7GґjXg`3^a؀n1g:aI#[{ݲm`[1wb#{ice KMbկHY^/'ǍX+Snhh-QRJNX?!K?IW^n?Ɇ_d sܓfՓ\iOQUb&<\ GHQ yf10SQ$0` 0` 0`ҟZ^"ȿDd˷ҺB bI;{yRl~2TS:VL%ׯ@F22iTIN}0?~uhMzݝ$O]1czQQ7ZԯbsZ1oPTP#;ܜ?9bڴ֝É!sRqr2>1Wu9FuhI-+86F&=:⢊dnw9UKb )JoWMG/eW_TMoYR,;TYACttLJr1DpU\ 译"Ƕ]˂kC?l,zX;PA^IEEWr̍L`E*ꖝ]MjvKUlՕ'ile%5%?.ZΩpY(E8'Y~rA!ܺzzZ͖#r;l"N EQplP@Y51@RK.&H}Dfl6 'L]#қ0(8wBYE^*axH<L[xў]h V?7JnZmfh`bi/rGHU:*$*8iN|d+l!kb}b4g8lunl-mc,$XYet3rDT0<6~'T_kiUuUTLƷ Lo0$5ae6NEUBX;@fϫs&1U*.Ħ J+Rs\k.\Z5h2,*U e'" P2&VꦉW9mqm';oxi]'{r w6KFJ9segg&Lp8J r @طB=guﻃO悄 }I }a Rw "I- ʽCU9g,MGp#kVLݬ5kQ]}imaOttěut#g2N]ub1Dr#նwԒ(SDQELT*e2TUC*(z,w+]ĝO&QT2k*`Wo_aݝr7fׁEn,Tz 9cGWUdc:poB< =_쏰lf^e; ߔct5qā1(ZC5U/q b0*NL=Fm6La0` 0` 0?ӟ5Ƶqv܁ZGX O:ba Zw#-Z|Q#8&۪*#6Qv TT-~JJV.;Jɞ(B\[Tǹo Yi6ߑ'_ =PO?jCdvt 0>wm?h=VϘH4ur(')rUN"0 "FONEmsvNXͪ.06 Y$XPq~B{DZNPH F~ύuA7^w$ɵѭy{10imd=[#(#tMOUusPH~R~1tp$D ̼xd\ܼ])mK*ͻ*}T/qb~ {l MI}Z$&]vB xm.“xlv*rkI""F&9z7%; 9QK<yD{mH[Ȃ${hz=evgp +á.痳OG+agU}+dTdڰF`P,MQUrڑHRn8ɲ%TO$Ym:Tdfς[t1G ģFSFN5}7!B΍8:9m냭CAJ9JE՘]G4i噟w3/8x<@R"[-8#^y+ݽ}d"}j4}-N RiȒ(@A".[& }{ׅdvp=mG ji!՟B;v¿oSzWF'R{Ru)ZUC,33Ss*r2*re2-Ly7&\6 a+/X{ }Qj7*7ASBml 멩89" {ES(AH ?Z'˾9k )::+3V %1JPðs^=XXR$T†Rd,os0) @ZӨ'6&>3kdX#[XVgD1r%U@7n~s≲ j5]HѶv9- /HrWeڬW|*x*(V7ogװ{jUSjrIw݇ Tɼ~ZjRmL`5hT@*$ KRd0daϩN}-~Ψ0o'4yv ܥ͛{‹ԊuCs{r, ?XkIܙȣX6 =ʫDLuTQ5u$oVvsSuƘNQ1!3r=Ic,GPmlhrW<Κe_ &Օ1` 0` 0ԟߑ.H}ZCidכo>k 1U8_,;p(}f]wSJBYP:HWHZN"D߉NK)_Bnga'_i%Lw/k ܇ 0/cS/ >Sxg ]#ŧHmV|*l٭3` 0dQp]$E@Kp8` 0 < ER129Q4u<t\|\xwB>>2&ﰨQ><Pna6)@*ѓPT*dVaP@@ ;97kZ?JDh6cN^#|:^Z(4bef,pQQ y Vt&kQI0` 0` 0՟_mfwHUYGu-[iV4 KS*N.c$q}OiCuF˵"bk%鴖ZA7J74KvmlT(Y7J#-%ەTPz5˽*h-ӍbdfD`iQm/"O (Fg}huħtU10` 0` 0aWeq6LaP]OP@nt=n,בz!qQȊέ9+'ָE"2:ʎf!Ԛ EOesGRWBbtUJwSO?y8VߏZkZ_7q$_g+S9'u$ +Y )"kۨJ=1fMbF_dᣴN@)Q%H#uMM;0` 0` 0?֟ϓ5*2]ƬS_ryJ-It Y1@%QS^(̻NE|Y$-ġDo[rk -ZT ނ!.T&ꨑ"B*M%AK*1=u eˍ?V~a,##` 0 n;Za.%VÐ zUz=+G` 0` 0ڞm~omGMQH:ܹpqW+#Ꙛc=霐9dd5NI}8+W% t"7y'Z`Mu pg@U2HDlfI Q16ML=d\~cz'݋0Ez!7v߭g/s^:ņ;ChWk}V/@юH(QPmcnc%*`q!`;ŵoqQ%Ii|{IqZZ>S?}?ĞLhif2zzl +Sq dOoU`!@nuLuJ$p.kQ^B]X,0` 0` 0П\Cݪej4m|ղ&xM+zYgʝa**RљVi*vZ >O -$3OˌQM3ӁQ*R$;y"i8i<,߮?M&$P` #!U H({ Q U}ʬ.ݽ`PkE륢U֯, yjDjiA2؍Y wbsRd$yr2nF+M6,WWZwwp)G&TV~B*2.ed"Wn$xlS>" pTZmI\l~c ITZyѰrr yW׋iC e9B&qVF1pc8~9dmSgFS6M}ayO/n,LCޥni,uV)7͝8nꬴ-RnX$u gpԙR6 {K{*#OДegR0HyVPжfo(ޮj쩙E<*cN< OWk/(vH\$U+/-FuRQJ.~rU4b!RtH?ݧ2l"rgśD!)(5t(uzr^ڡoڜ'\Us3,Aú(njJ($P1  vyg [.;>KYPuUiy%f'TU&ZeE'vL&cD(NM$C6R[7]:?մtSy9m;L'Tqh$k Pj} "#JՍe46o')&^([~#:3gYGLlvѫ ۹M5L&`) 5,5F+*Uw $V]$viejSP@# >(>#G9OB/vR5œIOݗ6E)E/jS)?xUP05O nP)di(=M7oʛZZnn:yWiv k?kW`<:I{]4AjuQG )d y^qԮ܂m$$[jۦeq8۷&m}Xt%$4񇞵]=vM N*6i*(zߤ1 L *v5WHnFh1MMlm^NdU=T9*}FNs*b(Qƿ?V'2Y'ʖAJ Ϗ\.j + rQZWoR8  |j~f֏gϛy7>E‹P!C(*Eo:.JS z$ߴ71^`65My6x*€f0"r,,=߫#<U&P6|sԾD0PLjנ@"#lb 4oѪKLK-s|_ؚZwryI/XRߑ/!ՒQpvEP\n Zvp6YZi4 -݅Vc`Qs-ŀFMeo)2!k=TRrnJ"5.9F#J~ʁU lLfm>Cfo!ʯn"o/eg:^r&$4!(/LA1Wv۵A*T2$%$_dڢ5Y.J'n]p@0N* Qɩӎ{o^\Jkmk^?gwl5,."n9#,Zm^:b =(m8*wt%d4[XU}n^k79%s`p)Jf(,nq骴-zj/W\Wd6ѿ,1mm%  U:7lH咦-Y(iȯFl2R/^8QU6ALP8UӶ#%~t#j~*@0 w>NqNdU.Iԧ8VP爆6hѬr䛹`b0PVkB땾WEM%6 I\U}eSn1*hqeyZeI  |B:d؝38vid嘠"7uhͿlʘ` 0` 0` ҟϕi7kI"-.dԏ*& = 'JN儿±(̫/ܧu!H1X-s6c,VY#tSR=k$0ɬ@/㙦R=5.R^ l䠎 0 r3ةVv ْ>nGz+'v\V~SQBC0kLYbNͶeSU]3e۽:Ss[-pYsV-TDXNBo[Q"d)Pw' ũ'1'8I85|CgmsGA')%#+.RXd3ls%8Y)}܍6~jv1_{Zw},܉NUb۠'묜~:$g΍,6xBlwL_X~ -%> .cML7xӆ/9lk.GL3p3tIB !fa}\g/=9ع;Z=3GJN܁7]ɫ2ThHyJ0Zp6qzo[{۽P֋6wTŌV{F7-iȻ#unB ,{i2>Y39yb*Fr+/*N>N9SA>IGW 7{(Ъ$n%9fP.nmS{vSk3xIQ5}J%I%]2c]H0)۸vDtTYӃ}Llq<n7G:+RhbTմ 6&DQa۷v9I4[LztE (lnYpPƿU)Mm1򒋟qP1I"MoAP<5VrAAlE1=AqpP9D S)Au 9C47/宐vVKdԷ\öjGJ ¶W(-_j`iE7j Kߋw*e-N۔ 陹$̵"a?cYWlS[:VbAuN`1CK}|yVmګP6ҼJB9hjMeΚ:ndS/DQzDA\,+I60ʿep(M5NM[Po+ݶuVj_"bY'oH8L#r-?>(Ð읪nݳ$<۲Z<~t(tjc\iɸ-ssc`CmHDzc8GZݫ!e}a#v-1td5/ED>r8g GtES6b6۪lܝlEĥo[ôDno[F9s@U1M5T.ѥWbVFkJFHzFUBɻȘA$MɤCpr0 \Rv%*`:,ZF(xz)ݞ˳e5G/{B%Wri6f 6;)cfN8CQ6aZܓe{TߚԢfLBi K{ߜ%*QB4ReZ衙<%VRC?%;(2,R%jÿnHӬa(qHF&` 0` 0` 0ӟIr=c[3v'J!K;eL.Hd3*uE;$G7'*^OD¤Q!8bfH81TO$`/ht}G.{%60^rJzQetLxg(:@P"0P!21|bRIs1a1Lc0&"#J鶒 5]Kw97ǗB6vMA/#m^Q)߅BȏPg!-~U?Q!o~Kd_RGL깇BI6#e"mŐнn`~EEy'i#{pPS0]:vYNZ}~AÇ*?9ym,q?>P 0kM\7z;Kd|Ŏux{<59XŻ˴T͝)RxMŭМHԚf5!1y-5\*tj ‰9R4N`TMpysC <c/ 0TLDFH7QNg^X,2j&a)@D0 u?"f#imz'v"čشWq`V4n) w\j M'M-j7 7=wT?XkoKJ,f>ZA bMl1=E"Y˵AE Qe%VlGջh+6o?Hk{T,bٱVR^}]*Ґg Y-J(E^UCSUm3+vZز-GaYWطD)j4(%^L^ӼPPAD| ~|6;f r"qd+jaGi_o31s9s"c&1#&1OI$Gm?0ߒF#mC2C]gVHrOq[E5P\E\a\JSDMuTnՒh]7_~EZ޷앁ŶP|LVnR ^,HH'>sQPe(6ky*v"Vx,0` 0` 0ԟߕe7c)$^MK"jī? QIb[*""%.QV_O|Yv\-O#@d5$bR%p T I'NMe[O.y1n~:1L0{ʬ9_$pB;fBlq<‡RNR٘,Nx>+=ݍqg*8E +dKL"m>Z/k$«9@doMߘh9sCdo#YQ2κLD OZ22 `` 0` 0` 0՟/daY{ҿtfӎsuB0ZLln:,px(̫?_8mIuѱ(!2irŨ`5O*Bɺq/-5ov{a.0`s;Kbd r\U Y3z>%}ʽ.ko|SĹ8-RL2N~2:MG 8v1ȭ2ԟʥhlq/7 xp)>_^!?ӯ]|ߧ;:%+zN;ꑩ^uAgl v޿f]kR)r藥<޳@XnԋY57Q#?ӚYvr2z83JPqZVy= 0=j)U"I&Q:rd(u1s@ʤQJm$z}B@&idNbPjrKUIXq"lcnIw{K{\Zw&2ֺ#3 G> L4Pc32Oͯr0wOBRVô. Qd?-behCH;XPG6хԕi_VjWX-=|J{` #hgQ6 6U+̊a(fs5 LcM:+U MD z'lm<L='\ݲURDPv[jn "$O)>tlo?|0` 0` 0֟ߕ^i=7֫mc6mW{]YĪRPIUiqѨ7U5BÅU&Sʲ9Ŗr8k5WX]lB2 [%Prhz: BSFSXUeؾ}9Ԙ%nqz;VirԹ(>h\ nvoK[ nk7>h!5ʚR\hRѓ~N9{xb.=SPCS|;ɾlIc;c3j UK2JQz4wMr3mmۤ܋S쒬Z6C6` 0%aW1/#LsU?bK~C,dz[֣(҇wnZ5/[ybS̤>JvDys}m,Ez k )RRD)j;*̕/A:ԉ6{6հ,/gʷŊ-ѳ۔7揷6ɷa''钬ѻ+·?1̿/p9<`)"M"UT0I$'QUT0I2aDGQq={sUnn4mVe7'Y{bYmp,PLЎd!ܺlq'(ӠWދFu׸rORj ( a)JD>stNOJ%Ի[e(nyQQs4Ii$b@."rl=~ꀇݜC?} 9*/KVmM~:WWgKUlƝ_6مyiIW?$]R5(_<KlfH|%/ "U;gո%XP+ ԧ$BQKE5VH:}:ʜuQ\Ҕ'H7Fӭ,z5õJYHXXJ=kz1"w3.7p tI0` 0` 0ן b([AIu~٠L.VD1Hl G)ܱN(dXzI9&d+g=lYcy8WqNnGu.䏔eݱ%w+HՋ[#u~~}SGԼwܚ {Hv#|]mF4^Mӄek&q˖E5IԫST]ioXػzLڽ8>I҉ UPy'/gBVw[2qjI'.1m6~FewR{|n5uQelyf"zG`:Թp)ȒL=$,rL(њ ~m(U}گJyە?bcY%٥#eNY`P2NúxDNx ˅\JV_jƜ'nN3R]A?A}zg` 0JF1@Z5C,G$ٷyRx\[sq~}w)FX h=>Y2ͳܷǺ<[^m2ޟ3xIYmЗr@*p=?Pʨb?grF+ywZy;ᑐe.X-==aOxf`omKC65GTٮEm7y=rr="REjBֱ/MFCݫW/M[)#|qM[ DNO9yak*r2,* %.|U j!0ϛ0foV,~d%n1vHJn{ЛMoYW'a\j_*)+/Nwr0nQCt>NnXs̹*nK^U Iv1Vy;azC4TSn|X>꼛2?>UX|>GH(Kc0K˜?^ApxsDTJq"KQAgQ*6VCf~wEJ&Q1̂-P2 >ۅ?0İʉ+鬰o>Ǘۄ5UUӲԆ,v9#u*Q4yɷ(C=sDб5frEI?@r|瘴I2|Lįxʖ` 0` 0ПT>Nܛ48n/`_MX(6g`Z%m-XwX'&xW?"Xe HOO*"W:cmo}Cz彷+|ЃRe(UȟyFZNnSjFyW*T_s>TWD|Ba8ZpZ7bvόZ ?K:2'/WɅ\ %OpEixzwrݱ0g۝xUw.M(ӽ6ھ{^Ƚ=SnYyU^~Uxs>;ᷡ&')α6ʳ~UĨ7߱:ɱҐTN65&Jz)/69AFrM""#b#`Eg'&WKșqXqS.Z/ 5lmL#M&Hs Ha2# @QxŹR?o(.g댗%ѷ7*>RQ^tcbRSUǘd54uâ[M6.4e.թ(3xDSc.P2nrrȷR}~/ұ&, 0` 0` 0џIn7LauuEO8O!<ߤF=E2_DrjWݩIz0+` (;G@%0 r:<='uoYxϧ&ħVѲV/P3Fݪ+TY$ȪcLPa}Tboy-4T6$d?+D^l)\үhV[>оkn>SE)rfmZ6z pVprw@P('[Gl^+s]q"rTzkX[l\#/ަjծxhZ>9;ǮK v2[d;6:BȔ[pb5@ 荟# g,Y؜T&ZOXU][ћ+ط(U*Қ[2՛CEk\jҍ"Tl͜SC=IETr&>`a/68n8K7 TPnj֮J QjNJ&Gѝ2_,NךerO^-E>۾;Pcҗ<{>f_!T+y ~ˊP@%9@{\b\Yqmr)Wi/֣*TOVq%roqǿFחZv7 6(H٧XJ"R*aLlp(L8}wљ֯\n[O"9+ԘӷW4U-^jI'ޛ(ܭˑv^*~ݽ4T^~G 7c :ˑC4Dd؇(2A2D{z>mzd\SKdfb;w{T4OwG:9A n":X\]g C1;#G3ci$.E.xwnŶ߂9{?yew6NH?ue:qܗf#`Ql&E4?Q7flU_aba$h S$'591hbהm*؟8r,pf>ho1VIR8 v_K;:+W{<,)Zuuخ}sx_r8/hKg`@\4,bn(|1鄠b;sWwncmќ{Ê$rs,-Qttb^9EjL! 1C#Y[wc70}֊W'JxtjWqv\ZT]U-eOy"HeChj4ǥޱ;`&SAezG!ۏO{w̃~}Ⱦm_,?=a%|>ۓi\ܵ2}~39&UArNW5uMKqd)= tzB>=IgJޡsèݺbYV09?;s˳tEE|ʜWb֑5>e]I~_w)ɭ^nexDzh 5"knYH%Yn6!<+P,!*><=]ȫRU0 Mz7sa(8coW)Қr(3Mgc+*U5>_ꤣk3zN:>NL{EG7^7IuU99޹Zzr &!9܅./x2HE M2E#ФM09~)@G(䢜Z)5/&_~n*_rU쌋˄'zvm[R#EF߽6w30=Q{% ??YQ% CYUZbtȾvsštMhۨXF,}=`ygTT#2󖑬].aX5H蔈:Fj0x` 0` 0` ҟI p<EzR?^;jDE#[Zꞙzv[Z*KnzwwoFkYdB;dyȽڦ hW[5Z1_{2z  ČxH?ndOơboٹ[m)X+sm\SbVON1\CVbZl~Rw NA)Hnڡ@7NC!NC !jSMڍVR` suk3hy7t)R!H?Pr5bȊם2m+nY|$fD߳dJ=b8dܵ\UTbԦ vۿnI;rUOA Br8qtgٗ#* s0딢(J3Z)5# Ɋ,Fv5۸O]!2~Jiӡ>5s.홧ZrӆkTc_ʊF4'oI5(6{(Ɲscf:,3z57"EJ%雍:j;wQfٜoڭj&3vq*&ӢZ"ۻi î94nsC]QT0C6Z=%0t{2ջcE䷱bڃxZwnѵx|6dfµ TTDI(L?c3qD ^|)NXY]oNUM҅2z72݋ZR/GwaXO4-1TbHԵd': Q}$dH PNzF_&rMjEWU]l{F[ZVKmj8VYWRAF!5p-dᩊbDlb@S1D!Ӡj˒+sN>͇ȳ'u15H6VsIe* [o1r{a_& vkޤ61nm[uߓpmK5|VUCFB XXXxfʃh**1nHP㘗o^'+ק9>.MVY Vb N(={z-Qw H|^C[4RhrȊ/#ChOR&0=c]Ařaٗ*~gYzr.G0zW?{t, Ĭe@-%0gDD =xL^ J}! :r<\TX)UO`%TuG+޷kcĻrVc krpvݶ誏]`蟦Mn2bZW9>d.ETi8Xr}*.ҚHb_V;]^!4ezU'K.qHqep9`8lM7vȎ8KKnm6;͔cO8K#2]⛋ML0` 0` 0?ӟjc7)WF֦Bcc_ D۸ El"ߨR1L!i޶~~rFdr׶BN=/.{-5\1~̞ )6iѳ9r1]ﶇ'9m!%ͮf.sjF>xS %Y3VS0x.謮꾠ٰo8%zDbMެc9A'w| |?coVX+F>߳5Y{߇X=Վ/;Q,;姫*˿fߤZrPi)P~L!|呣e: s/2.Ҷkuz>joߨUpU]uˬYeTQU"uaܤ)77ž,F* F)(GÆ9zvLY.Vl"Q:]pt۶nsNZ JQSr|KVbZp˒QVۢIqm]&~8 R}El&PlKתfdvziv)v@3,UY2t^_}ފUصfN˳$#eVsiDZ2&]N x%zݻP4ui(9{K(7>,]?}o]c ]ri5)bbMŔc\+ -M[S}d-g,M7#fN1ɸҽ?ڰ䔜TDPwrt5QϘZ3J(6(D[=LH[(y|:NC}Y}'un-r.*WK-OE%k枎-㢷Xn{MtWmIvK_kXy;Ni:Q?`0*MSpES1NA>.Nܺ[uvv:K?JuLץzj yn̴_nk5%蒤SL$c` 0` 0` ԟO6jn!ӏ֖zdH6M-!v[mMe U%7d25!BO:0hu(fTn=!x)(}^T3"(Fřn Fv|* YB1o59F&5Nvy[|2RhE{!1l^EF52\ZjTjHL{=\Z:]Nmӝ_fW6L;ѧ5.KmV⦵9T.`;L*CK9."S ڮZWz^(hO_O̩Q0;-\0jB<=E7=&dcfbɔWut= kظY}516)JY :lyٮ}z{}ICK5hɉ/Sv|S$j}a(bɺlpy7 y{Tν~Κ[3 T0Aq^q>o| O6p}EYF$\-K+Ȃ}ڽ.f:CcڢK+wC"1g͙ :*_d#?>ӧHo3@03 yU@l$a|{sRP3%rx*Sy~Cʬ$ =@$\*p P(\{ƌ|dܟQ+j$[ėzs$ ZI?&N㝗8-;88vޯ΢R{&(NzQª\h&;PۦjȖu)=bi ܅Wr2 j{J=:s# /rʳb͹*FݸOF),edع~)ͨ.'D&3绯5 PlJCGuꋴl g6+trq)E'n":;H.Qz-wC⻑G7n$7"Y9WQ}gݛ2r˄,E.ܔycJR17tJj M0̡$۳]?|BNՋDD BϢwZ]X;~fiN =ƻ_7^GC?^:9eqM5 %)ނSrPzv*carj OcpLi̅aʑ[}VHcU Ӹfq=;g?d m \EՔbYͷ>.ywJPi~TMwN .;V:o]١OJ-xV,GJCʻ" {yLOAoX1k>hJ㏽ZINT-U[t>d/6:s 2VfVy!r1Uy >j:$KDL"#]*V!.ӃاRJåN6uB="P?h0rR"%03mzɅ].kr[Fi2iq6\(X.ٜupiŴ-tVbHGJf b3PN^I&a KL0zw~buvG[w#З.ѥ~mU+Rq%XkV*` 0` 0՟'ZkD KlMwuVJCb:jL+tVHST9DRt}ξ3ܧ㽷em~7 זm}]nּޖF˫rn1cH>wuC*S3*U֞N6KTasL,y*%K0hqT; ;9z6UkOތ^|afO/\rKqn?m=Ge"_f,N1t>f.%9G[ZQbjdZiw.Y nJcQn2O5*ι>3O:pZ\?ui_#g^.:uq *(#FtQYzo +y`j?knI)[uKmK;-;VbdrT+4ی4~&K&;SPUɱRBR傈UέVM_iD{snʿn[f`ۗ-ROطvQuL}c,L,JVڧ*y {'z;J4Bxթ* #>rЇGRaO)QjKz*cvǖ2NJ\m#`0 Y!e۾+sqjҭ]Tls骔ˀQ-Q%9UboPNBq9Z:vLt_% i?Or-v%m\1׳R{^jw,A<|^ik":-3[@PTY)G9.o]={|r13-z7a(5V$l;noֲF4JܔEk4G|3Ui*AdQjTI3bԗ~w}{{Gӯ=URQ𦧎}p@?(҇РTp"g8:JQ0n*h$yEJ@LJ"cKPnU.\+"Ҭ3q,nhl (&*o$Bfmě=R([ڊsqMBikMY;5Vt8ͥV\&EK{pvZ 'ȺjuWMkk3g}Jah(H'W+ *Ee;RnedԡXze={'SXWJzZSV_׶7+F,n;w^t$"#ٿqnnIۗo'V턨?stHΜX~szBQ/9iEYrRi$%D+P-ϔp_.1z7q)6GHV-߲ef3IxH_ mՊQq%X :K((Y|b`E3NncF+:rOx2\9.T4[tiZVO}#}/#%_F|iWDur+q]wՅՃIgGfcvRk}6jȚM* g?FbeC7;};V|ZԣΓmJTIɭ?ϫ]SԹ%~[~%.HXԟ2nʧ'I(Uk{/-v  pR."c GαtW6}㊋vl۴W\t9vnqPܷL&W.i7ť)4В!pTQwN" ZLr$f]uN ! &0uM1nM%ov]&NM(%Vމ..̨CSqb mX6oqW=ȉRAUQ2bboΥҟI]ܰ6M?vj|h7ޕx]rkԿu /u\ i=Ucđ8=:F}fFLfZ1jֿEwvP*ϢzoJfabJ|U>sVqձʋӳ*Y9F;޷Qlaq17PNx *YLPt`uOK^ڷK<5B]5t77ԛJn7#*4v_:J-4j[ҬYU }NV]r)! % gNQJP)S>1.7qxQw0WjOU4 כO]mk3 J} jJJd@0` 0` ֟` |4f݁kQs6oDt-#tF=IV/&_BդX8'+{S]5ԗ͂Ҕl&veښJ9}YҶN6ۄ~(~fת›}Ne6-xe NԤl7=tǩ{z{w;V>M[5%⢟#\ƶPw۳5W~n1ۜӌd1׺=m066ŷ9 zm&c9aGCjcӻoB2zb݊fjM&GR? UlnfiMۥ$ xiJw(ㆥJ]H$ Eڝ ܡL9笶lKY{,bIF׿UTqZCU ο~or?tRyZmI4ԴeARVI5^%/]<@(~eF|̫NӨdK/;+~dy!(sGw;Lt^Yb"رjV2B3_2M?:=ڻvvB(w÷a"[WdA+#yb)crΏyT0 9]93º8;dR)ik{ldY˳G*۬fϚ>G͡]Xsۘl!6;?vWMޔw* uAEB%9;H1wtv͵mF̓N?s6ttuMH-Dk{uu&Sƹ$sni]m**5UJ6s'2InMlLD/kb9D(EZ$9_Uzw@ _E~\vNytH~ =Ko_jꬮJEq}ߊf ~ɢBV'H8Q'>;z7X{Ȥ@!P ϠI~cHZ)'mҰPN(4qI9kXִzזM$s9ioH!П2ghgru⺁7+N'aC+LٳnȷYVN 1tW#߮!vCp.J.q0JXPfV^*+#@SJp~a1g[QY5i㮝+umU֩$u1afx3R6W3P^UM}Yr;rI̪Kj#6DYRf$9 ;Myʏ@ɷszmc(ڝeGIsI:74J~ul,N ܓS*ǕM^jևm/QTt \*ٻg[I!LV@O9zLeZ=nUԳ/>ddjQ)MKY_:nG%qv~n.%`IWCV(o5 V\%F*.-)Zrˌejť_~ov{je7s$K=8v&ҢNeQRb! }[5jH:zS韡\Wڋ*.+U b_3uw _ N"4uQZJI'eC8:oh $Ԡ OOe-%> r ?G'fj|?Kׁ[ҟ&p准K&0Q0DGG$=S` 0@ڵ6NuT>:jYXԵZere+rSI40` 0`ן` X?)x|cC`kVbe嶌 =ЫDBguFl\+H\+_a//H7 ]ANk2)>ⲹ3#f=~MwFv'(-8/TZ4|s~[ױlM8MJ2N2OT⏜11LCD/-5\K-'E6ٚ{Tn[w\S6\tS X5Ӵ}33W(~f(:tn6ӽ[kv۬ۃn*ڣj46Ft۷=#Rv̓RU^>y==L)vl 6~\{5EW5B5ȼzF*#ATeu'>c=iRVVT^TTkޛ:SZlYEu'vI_$ꜜĕدQZK\ YqɊ|ux0\ 9&_ީ67 +tNӃT݇te/mB7IEJP/<|mkWVH~ؕw&4&b=+J3IvWRKރ檯2Rqt\h2E[^̱q(ӕ**T?k^uQmR:2Rms;L]-%MfmyjVE3`H YK9W69\rTa޵MNwZ8['vnZ6g4(jQ-k`q|jchU?<5ppAIs0ApD)8@n?m6~cح9Z#WsI%WتLΨ}+&Z ʋoN4(Ⱥjzn;?N\s@M{{K~~?d9'ÑyȘ;B^{BthҵT)%+S)@@pJ4֏z1Gנ>}LJ .S?YY$BV,SOTYs1*S@MtrN]oRLf̛nW/I')?"m YmbYF]NJSj1^YI%^iT āvZj]T5,vMX"I]SH>"ͳzuˆ"ګJոNi%^ū}#vЛ6zfqrO6tD^G0ޫ M'`yTI\7bXUIuU2cL} „e~Rp׹Ctt֕ cp(?U+w]=]+NG/#a[FH}d*GlX0E$'fVMO(#c%6ߕ\JRTfC ;VvxRۍσn嫬imsZ:{LpB` {})!6;U!FB:*Y6NV]|hCԉ_[~n.7[^p-?VN25u\ 񷏚ƹ9POXjs{,uB!X l?n6Q0:icøu`tO6\[Xin4?ZSIĄ=[V>v,+xQZ֍6lE)HDLM$"I$JDI"4I24LRRxoI$6m_y` 0ae*Rx-e#Uz(H{ɗD7C@(vv6=ţPdv5TlP}-[MLOUnAVc%NTi3?orT7mEUUs!]NT*2zD@ɜ5Eb^]Ӥw9Ms[+E(EovnTڒ|m:UK2ZIjR9%` 0` 0?П` 0 /=ڎv0pM.E[۠^"d0A0Eؔb&>mޖQ7;X?NR?T~Y-cvcI)i )KHΔj8rJ6BJBYH#X;HȹfEvp霣Y%\VMdG}C.~A vջvی*I4GWnع.cQn2^FktYa.Xkh+M03B 2ǯ1,;^<>U6iwQ3o[Mz;W7œ\C> M}?O`LHd据i(C$LHaED~^eщ6Qk^y 7Voyxׇ=8:12WM 95@\Qe;bJsT)ǸD~s:jwy:ٷ_:=g,KTj")ihS(TT<]t !n+.X$QǦHAC]XEJ'Jm}AÎ?WfJ㢜q~C y.ixBfB_0RlWo7[zo|-ÇúRͯ{e]Vq\}'_Mi4;|_J-hwJ][Ip+eL "'D \6]cղǙ&_mYSkMLRO6ux(%4Ҡ[$ߧaD ?vm1p9+f%Frw 7_Ni&c1.ꏽK6nMq8:sښ JZ2d| 0` 0џ` 0b[R9kIlDHƤ 0HYiU?(y'Y?L~Keo7ܗ'țKOKּ\7V4]IjUȄV_^qک,eEVw L'AtTȨQ)` >9'IJISOTZ4֩(p8܋iN4M=zz` 0` 0` 0` 0Xhk)+YN")D F-;\v?RTrK:Gn{~jQȍ]VVQZjekt> JeF;i8mhvmU4rRp pd1{l711Vflj麥*1L@sڷv38FQiQzѧޏؽz6M[ȷ'FIFKG'iLrh` 0` 0` 0` 0Wi ZV*&E+m§,e=3\1A!CDve—Wj^>±nz5âx;sTW^}U|ZŸT۵E8d젛J ! $B]D7)-޵1 )˦7KVk]c%܇db):4K>F>^5IEӞnkQ5I&L$#` 0` ӟ` 0rQlvst`[L|RvPDNvu_RrNvSӖk+-go=%ZJm0㤸FKKw;!s~V?e e$ DYkLN7j.J`S@Ϯ2񳱬faލ[REi=xy[~VFv/5_ڰ<oӷEM $o1HIjR:ML=RTR\N}פ;nkvP~ѣޑ{zErܿ:k 2^얱eR)` 0`ԟ` 0NVqu=hHA۵1@; ,/Pfq:O%m>=Vٓpฯz>׍U_c^B6)w/s e0#$ٹt3wl6PRp:K"D 9Vmdc݌(.Zi)߱\2nN3%'Ge` 0` 0` 0` ov**6UE xy/nJc&&iz4G.F` 0` 0` 0`oPnޓr""ʨmxK tzzT3rEH1n ^&gO݊bb_Rސmw~M|2Ի$%J4|USV]M\ j/RLw"tӀv,B9RһrIXM|7!W8.z>꽫v|}i[rp.ks]𒤣TʗJ0` 0֟` 0` [vA7^7mPG̓M(Sjml)^ԜB. !T'do6N[&9Obr']xl_ TFoF9)w |3CO#^;hᄃ+|FA'T2.Z@Et }m[bgbqREѦLׯcdZ2-QjQ]Z|z4|t0` 0` 0` 0r]>@EEP *(06IZI7\d nb3'uf<I~ԟl_v/ݒF]#[EQv|5Ff7TTuooRbnuY&)ҔZqi4֩OQqrRM5M=SOFE` 0` 0` 0`@N~eJUU@BM(ne63~ Aߢv][mo%W '.+⎼gBnƭݮ_>zM/չ˃eU:ja+e"Hsv&i'"갓dq1!)3bzsv}[faBJZ5Ti=zc^#l.x2R\$}TԨ٢$C` 0?П` 0` 0 WlRzѣhHw3PDLM@*L_M؝.J{+tsW+᫆5^}!_{UkH"7kJ09`b;f%:nJ D)37dZ~E'ik>;f5o"qddqz3˥0` 0` 0` 0`[ͣmP" v*:0'R.DXJ f:fWtXm76BuuE9[xUSURRk^)2a=iFou4v˓.ŮGIEQMSiOKnz'jVʠ1zd3ʡ:J {\tC/=YқHnw܍y.BU EF辳zh뵷ݵ*sڝ+*qOdiWr0K` џ` 0` 0fFbQI>d<$mnn܀ ͜ ڛ^Ư?)ܗAO};җ훤w.ee3;}_l\ݶBS:>K.>SH\eXӗ 220slELD^>N5BO[Hu9 P)@@D>DZz71nEJeS/'+#6ĭfY%IFKF81` 0` 0` 0`G&%k!_tYk*tNDyhnj(Ǥ:iۘ/EZ]ҕ8SM&Lz7.ޡXiF֞KZ=qm9Smʬ ƺ]Bأ[ITPpNArtP2J(Cψ]/fܳvrظ%UڻTin[Ձm9m)>E2]4vlכ!0ҟ` 0` 0,VLWʄ.Ύc尐XYlQ2Svcwa: >ކշޞ?N5FE$Yħ!CLQ+;fŹ(N.QzNS L fn%-kqc0` 0` 0` 0/6 0 E(e!eTO[_L&nI9vV޹b<}*[W9U#ΒKNxN1t;ӯۇEXfa9Q:]/咯*kZIT%#>_<e].SK ~+.$ SDSxmW–{!$bnI(\i4)F>Fώv.[v->ع|TZ|kTTLd$#\y.= :j>|!88w;W34'8!n4NSJ-9d 0ӟ` 0` 0rϋmvbZktlȆv 9z)Єl3poJdO:^veNj7TՏֺ[j0[04K" IM/'ӎ5tӖ/8d`W~ާo;[֣"Wh#J5‰"j"*(ȬY0TVI@*,%1LbtTBqRN U4|k}Q%(N-N-MqM=SOFE` 0` 0` 0` e1 &Z5n*'ITlD(@DC1qq1X[q$|GĿg3"vJqd4֩C1bS-'^lDSZ&dӈA1H3'p"ȸ?w%0,_ҫ?o+|UW; 5מzsi(sUVGL~Y[}=PVEFU%š|kˬdGH\c՟` 0` 0`+[R.eVFؚ@+tM+q}ǻ0w/}ҹ Qe+2}qv_NdyozmmwӤa~ ^\"W?.}L|0` 0` 0` 0` Ӧ.bfoA'mdj]( &SC!ڷ~7fqq^Ū4ji˖ݱv/BJQQuM&^oX?? $iP8:0L*5PCoa_GNJr_siUkTk+n}=v_ͷ qiU=(g::֟` 0` 0`by`ZFu`@Kl'>")srē{%9F^*.K8/ mefN ܣE3g'ƃ` 0` 0` 0` 0aڧXkuag^=?ABu*8L n1Y#~9?\f񁕶nU;qiJ./i3c击ݼR{S]e-f9R>r"o)O&%fJ4yUzU;̆ɟs]pUbp?ɤOMrkg->}b/ jǯ +帧uKT?ן` 0` 0`+aԶJb&3&]E RXb{d Fq&=ԟSm&۷y.Sˤ׌H/~zKrm ^W䚬#в YfΑU*e)2KY35TS|@!r[ JܒiSOTMQp8܋iM:4cOF^{<0` 0` 0` 0`j3qָ' !O=]tɔەЋs)m9HKƼ3V#mJ~DПo`:Raݢ di0d#kOsz#x3UѪ Qt~׼8?$_dZ)Ǥr#37XUb^NB^ #5z@S~]HCQ8JHTy N1O?$)8-dبiuBlQO$N>jnۚ.CuU/o:˴7g>3ɡyD8CT6ovcj}$qv uIQ}<,^ vT0 ٜ~ ^lƣhs6ʳiXVdMdi7.,P.mN)J"(. ÀZVcv![T{ƺE^?lh7g젙f` XҜ"5Ekxj Qt{XW4\Ƅ'/ ùprn,%ûc~%`n cj^8NOÂbBD_+ L+v^*B:&RT5r&1!xxn&Z9MQjL&M`vܚUb5*TYlS8]k?PHfi$31u)@U;VMǫ/HnQH;^=y:U=}K^;x7m!0C@ꜬZyK3֎?~?l]Cj.ELl:,d8e!&ૢ;DT0 ׭Krr+U,:1neMF'0@bdOYI0*USE ^5eЧjF2}Ն"uXIcӋx@R0 KQ`zuc+(vI Zw G3=JeDI!nvlz4C&7޽*)WŎbzۊ/!ϡO` 0` 0` 0` vU 屦$rg1D7fC ?PH5D|T]D5[X3*vF+ޛlY69/>3`d24lh:,ó-v70DBҤEƺ;.RͷϬ1v= +rv+*1P檋n·Ѱápg&k!~U-[Sjtr%NUџ9@rOd\׶5^šhZyO\5ʯY'k;炙v|]cqqfش6ˆ0mjƔNJD-9bc'f9Gl8X̛Y1aͨ;uz#v~;>ݕݿf}?EܴrzZJpdHdAڱjOs>֞4fΡˉW w)ЕַObê4;eӑ$z|I'"KLmڴclpA{..7CqS;_G唩:p_mM^I͎(Lj7L+?ktk+%'{.h{6k֞;FIǖz(yZ됴BF\r%d:ty꭛g=Gh~.$ nšPl;F_&kfCg2ġJ [A=Zt+^۾;ZU)xo h.:fENLM>* H+i'xk1{h3- _gz]v%"54jΊ3M9Aupjj/ WTJ`-=Xc:WһԗZ-nݳ4撔m&V#Ս*[Ţw+f]Pyh^m39D ŮO7:G2.X5UY5$b&#EYI{w^=_mrpIq"\їG1'8oxkn-km\r2 YeQtq\5l)3;A_U%F-;O-vy/Znn|ȮTjI kqkrZ ٵa0c&Ump#yGD0+=%nj]kĈEin?IjO+if&{xʙΚFE=ѣަ`/؎5e Νzj;3y|j s >.ZwԡpFu_k{Tj9F\ ^sb:eS_~JN vNqnL P2w~R{Wk\4qTHæ3PlXt~1=ڟ쌫,S;9†` 0` 0` 0`T77Ō&KHW3dbe B}G5mV1Zdzrq~J2lmNXF'#mBSkD|]+; v@!IJ6=#!}BTH@~7=# 2HrH3lAzrQ_˧)ļJ榯wIY݀1)ucu>-Q~;PYml;{V=+O/sUa_On/o9W /NTc@bClP(9O5Sx7#?r7\eYoˌ''hvfņՁg<#n* _f?ҟ` 0` 0; ZVG\5*p;l~fA0c?)TY&Lw<0>9]J2k#`NlD:+"G`˶oƽk#߄ڔZTiYDZb6U\Ɯ\e%(>)Tf,9KpQv\X$j3e:-ܢ,uܙ6+ :)|鴭d4W Μtc>Zb=ΠFA7{5QYn[MaH:gЩT>e?r` 0` 0` 01@@b "?pGV*TƨA U5p9gcȸE'P n=OӻJķ[2]oSr~AtSN?º2_lmK<Ը,=ΖGjrJ(0#ԀbosWFGC?\~Azp6 \h%96Z( Θ1de!9 gCxg>ܾ~dvŘݕJ\yN.{==ȿ*{ѵڍ{%OCֿž;@.G#JZuTĢ@7zdQL2g`Vbp*K'[o{}w+%\q/ [bez* 9/CǵfNԭ =Ө/73>3^rsMa``#ڱF#4RG-Xӟ` 0` 0` 0gOzdIX & ,ᚌ*1r2z k曩{L=O>>Ï渿ڢJ~ܢp"Ώŋ2g0ʋƚ_˵}'<O(;><;v_#_쳧˷Oczrrvڍߛ_Eqk.75A4\ SzλD~rP ׷')kv^OsĜZ5ո}9QֲyN=\< XڲBjLzHZA3PQ?jê:ve^OW%J|K6ΏmEm}=eڇ7m9?;*@tf0`ԟ` 0` 0` 0T_MSQv68W~ess oOfG?P]Gߤ}O_rw?%k>9%}9i9/Ro9 _=}w<wWO>ͅ^ʳ/|ӓ7~˰\%g!ԁse*|/?ݟ??}{`?>֏=ݟG1c⿴dz=<rӳWSݿ^Z_:zjU |?ďsp<>gϪ9?+ꧼK\)9K{`=GoA^oߐok~m+WX?DC__"۟k|m # E;>DZڱ;::֯%ꔰ{JtdN1O6+3+l1򩵵v}4-n 4EȋĬkӆRn'05 l5}2& onnkVֹu}eUy/>讁 a0LK uOg/3/ 8;Fi?&9>,k;l& Z\=rzvSmXkfjk)u]_[mT犅s=Gpf|S1#?;$H~֘ʦN0"׹n`kXYfU+}cu,m{I-voz~zOJ1֏VPjs}?P7w ^~=T|zlp7/.'OWT, sKkuu$6_"YC2eaĤI$KuvѵcbljI].}Vk~CĒ\Oso)E_Oݝe8汹$XI-G"s=cQ,}& i-%%0@}?M^tf&le遴:s?ҳ[󾧪=5WX97]k gOpsF]uV&.[lX7uճhش~^P#ov]ʦ>#YN!%E,sh{,fuUYѥp^JeG&+*77s^ͶޤޢjFMտGc7~Yo[}wYcFFEF۟~݁Sc+$ @Zέ]Ng+:KwPuLc%o4tM-%;߷s^8GͰ4<ګ~K-_6$⳷_G>n7δGfs}]ٷjtO" A1U)&,m2\G?͕⛞49Q]܍"G6=n (tF4ƌfsĹ?K&˚Úw?2U)$+P6_leZ&׹}'1ߥkn?K^#%KQ#{AX/E:HnkMߦs1v)`lo}=Kӯ]Ciۻc=̉$*Cgj /&-;Eov<]CaIk^k,k{=\Ʒw?*H {V~=-Photoshop 3.08BIM8BIM%F &Vڰw8BIM com.apple.print.PageFormat.PMHorizontalRes com.apple.print.ticket.creator com.apple.printingmanager com.apple.print.ticket.itemArray com.apple.print.PageFormat.PMHorizontalRes 72 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2007-04-13T15:57:03Z com.apple.print.ticket.stateFlag 0 com.apple.print.PageFormat.PMOrientation com.apple.print.ticket.creator com.apple.printingmanager com.apple.print.ticket.itemArray com.apple.print.PageFormat.PMOrientation 1 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2007-04-13T15:57:03Z com.apple.print.ticket.stateFlag 0 com.apple.print.PageFormat.PMScaling com.apple.print.ticket.creator com.apple.printingmanager com.apple.print.ticket.itemArray com.apple.print.PageFormat.PMScaling 1 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2007-04-13T15:57:03Z com.apple.print.ticket.stateFlag 0 com.apple.print.PageFormat.PMVerticalRes com.apple.print.ticket.creator com.apple.printingmanager com.apple.print.ticket.itemArray com.apple.print.PageFormat.PMVerticalRes 72 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2007-04-13T15:57:03Z com.apple.print.ticket.stateFlag 0 com.apple.print.PageFormat.PMVerticalScaling com.apple.print.ticket.creator com.apple.printingmanager com.apple.print.ticket.itemArray com.apple.print.PageFormat.PMVerticalScaling 1 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2007-04-13T15:57:03Z com.apple.print.ticket.stateFlag 0 com.apple.print.subTicket.paper_info_ticket com.apple.print.PageFormat.PMAdjustedPageRect com.apple.print.ticket.creator com.apple.printingmanager com.apple.print.ticket.itemArray com.apple.print.PageFormat.PMAdjustedPageRect 0.0 0.0 734 576 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2007-04-13T15:57:03Z com.apple.print.ticket.stateFlag 0 com.apple.print.PageFormat.PMAdjustedPaperRect com.apple.print.ticket.creator com.apple.printingmanager com.apple.print.ticket.itemArray com.apple.print.PageFormat.PMAdjustedPaperRect -18 -18 774 594 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2007-04-13T15:57:03Z com.apple.print.ticket.stateFlag 0 com.apple.print.PaperInfo.PMPaperName com.apple.print.ticket.creator com.apple.print.pm.PostScript com.apple.print.ticket.itemArray com.apple.print.PaperInfo.PMPaperName na-letter com.apple.print.ticket.client com.apple.print.pm.PostScript com.apple.print.ticket.modDate 2003-07-01T17:49:36Z com.apple.print.ticket.stateFlag 1 com.apple.print.PaperInfo.PMUnadjustedPageRect com.apple.print.ticket.creator com.apple.print.pm.PostScript com.apple.print.ticket.itemArray com.apple.print.PaperInfo.PMUnadjustedPageRect 0.0 0.0 734 576 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2007-04-13T15:57:03Z com.apple.print.ticket.stateFlag 0 com.apple.print.PaperInfo.PMUnadjustedPaperRect com.apple.print.ticket.creator com.apple.print.pm.PostScript com.apple.print.ticket.itemArray com.apple.print.PaperInfo.PMUnadjustedPaperRect -18 -18 774 594 com.apple.print.ticket.client com.apple.printingmanager com.apple.print.ticket.modDate 2007-04-13T15:57:03Z com.apple.print.ticket.stateFlag 0 com.apple.print.PaperInfo.ppd.PMPaperName com.apple.print.ticket.creator com.apple.print.pm.PostScript com.apple.print.ticket.itemArray com.apple.print.PaperInfo.ppd.PMPaperName US Letter com.apple.print.ticket.client com.apple.print.pm.PostScript com.apple.print.ticket.modDate 2003-07-01T17:49:36Z com.apple.print.ticket.stateFlag 1 com.apple.print.ticket.APIVersion 00.20 com.apple.print.ticket.privateLock com.apple.print.ticket.type com.apple.print.PaperInfoTicket com.apple.print.ticket.APIVersion 00.20 com.apple.print.ticket.privateLock com.apple.print.ticket.type com.apple.print.PageFormatTicket 8BIMxHH@Rg(HH(dh 8BIM,,8BIM&?8BIM 8BIM8BIM 8BIM 8BIM' 8BIMH/fflff/ff2Z5-8BIMp8BIM@@8BIM8BIM[$nSCA Prevention Logon$nullboundsObjcRct1Top longLeftlongBtomlong$RghtlongnslicesVlLsObjcslicesliceIDlonggroupIDlongoriginenum ESliceOrigin autoGeneratedTypeenum ESliceTypeImg boundsObjcRct1Top longLeftlongBtomlong$RghtlongnurlTEXTnullTEXTMsgeTEXTaltTagTEXTcellTextIsHTMLboolcellTextTEXT horzAlignenumESliceHorzAligndefault vertAlignenumESliceVertAligndefault bgColorTypeenumESliceBGColorTypeNone topOutsetlong leftOutsetlong bottomOutsetlong rightOutsetlong8BIM( ?8BIM8BIM {)@ _JFIFHH Adobe_CMAdobed            " ?   3!1AQa"q2B#$Rb34rC%Scs5&DTdE£t6UeuF'Vfv7GWgw5!1AQaq"2B#R3$brCScs4%&5DTdEU6teuFVfv'7GWgw ?TwR=8veH]+uLF0R qSdX,XGBunN~M.klc7n59?VoQ3&{V[TkueVeXyַ7HgMr!{0!3dl&g+/UU~VuB;144cwWFmcV6ޡ65{>{JtdN1O6+3+l1򩵵v}4-n 4EȋĬkӆRn'05 l5}2& onnkVֹu}eUy/>讁 a0LK uOg/3/ 8;Fi?&9>,k;l& Z\=rzvSmXkfjk)u]_[mT犅s=Gpf|S1#?;$H~֘ʦN0"׹n`kXYfU+}cu,m{I-voz~zOJ1֏VPjs}?P7w ^~=T|zlp7/.'OWT, sKkuu$6_"YC2eaĤI$KuvѵcbljI].}Vk~CĒ\Oso)E_Oݝe8汹$XI-G"s=cQ,}& i-%%0@}?M^tf&le遴:s?ҳ[󾧪=5WX97]k gOpsF]uV&.[lX7uճhش~^P#ov]ʦ>#YN!%E,sh{,fuUYѥp^JeG&+*77s^ͶޤޢjFMտGc7~Yo[}wYcFFEF۟~݁Sc+$ @Zέ]Ng+:KwPuLc%o4tM-%;߷s^8GͰ4<ګ~K-_6$⳷_G>n7δGfs}]ٷjtO" A1U)&,m2\G?͕⛞49Q]܍"G6=n (tF4ƌfsĹ?K&˚Úw?2U)$+P6_leZ&׹}'1ߥkn?K^#%KQ#{AX/E:HnkMߦs1v)`lo}=Kӯ]Ciۻc=̉$*Cgj /&-;Eov<]CaIk^k,k{=\Ʒw?*H {V~=8BIM!UAdobe PhotoshopAdobe Photoshop CS28BIM:http://ns.adobe.com/xap/1.0/ image/jpeg Adobe Photoshop CS2 Macintosh 2007-04-13T10:57:51-05:00 2007-04-13T10:57:51-05:00 2007-04-13T10:57:51-05:00 uuid:0592E01CEB4011DBB3A0ACAE717D7B2C uuid:0592E01DEB4011DBB3A0ACAE717D7B2C uuid:A918BDE8EB3F11DB892EC7BF6868889E uuid:A918BDE7EB3F11DB892EC7BF6868889E 3 sRGB IEC61966-2.1 1 3000000/10000 3000000/10000 2 256,257,258,259,262,274,277,284,530,531,282,283,296,301,318,319,529,532,306,270,271,272,305,315,33432;F8F1A24EF806E2CD82905BAD3DEA6230 2158 292 1 36864,40960,40961,37121,37122,40962,40963,37510,40964,36867,36868,33434,33437,34850,34852,34855,34856,37377,37378,37379,37380,37381,37382,37383,37384,37385,37386,37396,41483,41484,41486,41487,41488,41492,41493,41495,41728,41729,41730,41985,41986,41987,41988,41989,41990,41991,41992,41993,41994,41995,41996,42016,0,2,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,20,22,23,24,25,26,27,28,30;DE7B28D2823B4A2AF8C8A525997C6B41 XICC_PROFILE HLinomntrRGB XYZ  1acspMSFTIEC sRGB-HP cprtP3desclwtptbkptrXYZgXYZ,bXYZ@dmndTpdmddvuedLview$lumimeas $tech0 rTRC< gTRC< bTRC< textCopyright (c) 1998 Hewlett-Packard CompanydescsRGB IEC61966-2.1sRGB IEC61966-2.1XYZ QXYZ XYZ o8XYZ bXYZ $descIEC http://www.iec.chIEC http://www.iec.chdesc.IEC 61966-2.1 Default RGB colour space - sRGB.IEC 61966-2.1 Default RGB colour space - sRGBdesc,Reference Viewing Condition in IEC61966-2.1